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1. Introduction 
1.1. Biological aspects of chirality 
The importance of enantioselective analysis in organic chemistry, food chemistry, toxicology, 
agrochemical industry and in many other fields is rising. Nowadays these analyses are inevitable 
for research and development of chiral compounds. In pharmaceutical industry it is important 
to determine if there is an enantiomeric impurity of the chiral drug, also in organic synthesis, 
when enantiomeric compounds are used as chiral synthons. Enantiomers have the same 
constitution but another spatial orientation of atoms or of atom-groups. Enantiomers are not 
superimposable with their mirror images. They have the same physical (except for the ability to 
rotate) and chemical properties.  
Speaking of chiral molecules, chirality plays a decisive role in biological systems. Chiral 
compounds have different activity and kinetic profiles of the stereoselective binding to chiral 
targets like receptors, enzymes, ion channels or drug transporters1. Therefore, enantiomeric 
drugs can have different therapeutic effects on human beings. Enantiomeric drugs that show 
positive effects on human beings are called eutomers and the other one which have no or a 
negative effect (toxic) are called distomers. 
One enantiomer can exhibit undesirable side-effects or can act as a competitive antagonist of 
the other and the drug would be less potent in the human body. Therefore, such a substance 
must be separated from each other when used as a drug. 
 
There are also many pharmacokinetical differences like in protein binding, metabolizing and 
also pharmacodynamical differences. Single enantiomers of chiral active pharmaceutical 
ingredients may differ in adsorption, distribution, metabolism and excretion. Furthermore, 
pharmacological or toxicological effects play a role. For instance, in the case of α-methyl DOPA 
there is different pharmacological activity. (S)-α-methyl DOPA has an antihypertensive activity 
and (R)-α-methyl DOPA is inactive (an isomeric ballast). Furthermore, enantiomers can have 
similar pharmacological activity, but different quantitative potenties (e.g. as β-adrenetic 
blocking agents do). 
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A lot of flavouring agents are chiral. Their flavour and taste depend on the configuration of the 
corresponding enantiomer. For instance, limonene is used as a flavor.  The (R)-enantiomer has 
an orange odour whereas the (S)-enantiomer has turpentine odor. Giving another example, the 
(R)-enantiomer of asparagine has a sweet taste and the (S)-enantiomer has a bitter taste. 
 
To sum up, there are many effects that can occur if the drugs and biological compounds are not 
enantiomerically pure. Therefore, to avoid such effects to happen, the FDA (American Food and 
Drug administration) claims that there should be invented stricter levels of optical purity 
(>99.99)2. 
Chiral building blocks of drugs are in many cases amino acids. Amino acids consist of a carboxyl 
group  and an amino group. Amino acids are amphoteric species, which means they can act as 
an acid or as a base. Besides, they are zwitterions or molecules that have both a positive and a 
negative charge under distinct pH-conditions (dependent on the pI of the amino acid). 
Moreover, single amino acids build up peptides via a peptide bond and peptide units build up 
proteins3. There exist twenty proteinogenic amino acids, which are classified into essential and 
non essential amino acids. Essential amino acids are amino acids which are indispensable for 
human organism but cannot be produced by the human organism itself. 
All naturally occurring amino acids that make up proteins are in the L-configuration4. However, 
there exist also D-amino acids in the human body for example D-alanine and D-aspartic acid5, 6.  
 
1.2. Enantioseparation – enantioselectice HPLC 
Enantioseparation of racemic compounds is of great interest in many fields of research, 
including biomedical research and food production7. 
The requirements concerning chiral separation are very high. There should be high sensitivity 
and good reproducibility. Further requirements are that only low amounts of substance are 
needed and simple sample preparation. There exist many techniques and methods to separate 
racemic mixtures such as crystallization8, capillary electrophoresis9, simulated moving bed 
technology10 and enantioselective liquid chromatography. High performance liquid 
chromatography (HPLC) can be used for chiral separations very effectively. 
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The main application of using HPLC in this area is the preparative separation of racemic drug 
compounds and for analytical determination of enantiomeric purity11, 12, 13. 
 
As mentioned before, enantiomers have the same physicochemical properties. Thus, they can 
not be separated using stationary phases with an achiral environment. One possibility is to 
convert enantiomers in diastereomers or diastereomeric associates, which differ in their 
physicochemical properties and therefore can be separated on achiral stationary phases. 
There are two modes that can be applied in enantioselective chromatography: the indirect and 
the direct approach.  
 
(R)-SO + (S)-SA         [(R)-SO......(S)-SA] ǂ 
(R)-SO + (R)-SA         [(R)-SO......(R)-SA] ǂ 
A 
(R)-SO + (S)-SA       [(R)-SO--(S)-SA] 
(R)-SO + (R)-SA       [(R)-SO--(R)-SA] 
B 
Figure 1.1 A: scheme of direct method (associated), B: scheme of indirect method (covalent bounded). 
 
In the indirect approach a diastereomer is formed by formation of a covalent bond between a 
chiral selector (SO) and the enantiomers of the analyte, the so called selectand (SA). Then the 
formed diastereomers can be separated by achiral chromatography  (e. g. reversed phase 
column). These formed diastereomers can be separated then by achiral chromatography or by 
electrophoretic methods14. However, there are several prerequisites for the chiral derivatizing 
agent (CDA). The CDA has to be of high enantiomeric purity. If not undesirable side-products    
(= diastereomers formed by the enantiomeric impurity) can be built. Other important 
requirement is that kinetic racemate resolution has to be avoided. This phenomenon occurs 
when the rate constants kR and kS of the (R)- and (S)-enantiomers for the derivatization reaction 
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are different and the reaction is stopped before completion. The enantiomer ratio will depart 
from the racemate ratio (50:50). Thus, to avoid this phenomenon the reaction has to be 
completed and CDA should be available in excess.  
In contrary, the direct approach relies on the reversible formation of diastereomeric molecule 
associates. The SO interacts with each of the two enantiomers and forms diastereomeric 
associates. The difference is in the different binding strength of the complexes. The direct 
approach can be carried out in two ways: 
In the first case, the chiral SO is covalently linked or physically adsorbed onto support material 
(e.g. silica). The mobile phase is free of chiral additives. As mentioned before, the 
diastereomeric associate is formed between the chiral SA and the chiral SO on the surface of 
the CSP. The enantiomer which forms the “stronger” (= energetically higher) diastereomeric 
complex will elute later, the weaker diastereomeric complex will elute first. This method is 
easily to carry out in practical work. 
The second way is to use a chiral mobile phase additive (CPMA). An achiral stationary phase 
combined with a mobile phase containing a chiral selector. Diastereomeric complexes are 
formed between the enantiomers of the racemate and the SO than in the mobile phase. One 
enantiomer interacts stronger with the SO as the other enantiomer. Thus, they are eluted at 
different elution times14. 
 
 
1.2.1. Chiral Recognition - Three-point attachment 
In enantioselective liquid chromatography chiral recognition takes place between the SO and 
the SA. Some models were developed to explain the recognition. One of them is the three-
point-rule from Dalgliesh15. Later on, Pirkle expressed the three-point rule in a more general 
way: “Chiral recognition requires a minimum of three simultaneous interactions between the 
CSP and at least one of the enantiomers, with at least one of these interactions being stereo 
chemically dependent.”15 
Not all three interaction must be attractive, in many cases repulsive steric interaction are 
involved.  
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The general principle of chiral recognition was initiated and further developed by Davankov16 . 
This model makes it easy to show that the sign of enantioselectivity inverts when one of the 
three interaction is repulsive and not attractive. The three point interaction rule differs from 
the three point attachment model from Dalgliesh. According to Dalgliesh, repulsion is seen as 
productive, as an attractive interaction. In figure 1.2 the three-point-interaction-model is 
shown. The classical three-point interaction model is often represented by amino acids in ligand 
exchange mode. 
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Figure 1.2: three-point interaction model 
 
From a thermodynamical point of view enantioseparation is based on the difference in Gibbs 
energy (Δ G) in formation of two diastereomeric complexes (equation 1.1) Δ G°R and Δ G°S 
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express the affinity of the enantiomers to the chiral selector and are related to the equilibrium 
constant KR and KS (equation 1.2). 
              [1.1] 
 
     [1.2] 
 
T … temperature in K 
R … gas constant 
 
The equilibrium constants KR and KS are related to the retention factors kR and kS by equation 
1.3. The phase ratio is represented by Φ. 
 
              [1.3] 
 
 
The selectivity coefficient α depends on the ratio of the retention factors of the enantiomers, 
where the retention factor of the more retained enantiomer is divided by the retention factor 
of the less retained enantiomer (kS >kR). This relation is combined with the equation 1.3. 
  
     [1.4] 
 
When combining equation 1.2 and 1.4, the relation between selectivity coefficient α and the 
Gibbs energy ΔΔ G°R,S. ΔΔ G°R,S expresses the difference in the free energy changes between the 
(R)- and the (S)-enantiomers. The relation is expressed in equation 1.5.  
 
   [1.5] 
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The free energy is also connected to the enthalphy and to the entropy which is expressed in the 
so called Gibbs-Helmholtz-equation:  
 
                                                       [1.6]  
 
When combining equation 1.5 with equation 1.6 a correlation between the relation of the 
enthalphic (ΔΔH◦ R,S) and entropic (ΔΔS◦ R,S) contributions to the selectivity coefficient α can be 
established. 
 
                  [1.7.]  
 
Using the van’t Hoff plot (ln α versus 1/T) where ΔΔH◦ R,S and ΔΔS◦ R,S can be determined by the 
slope and by the intercept, respectively, this thermodynamic analysis enables to find out 
whether separation is dominated by enthalphic or entropic contributions. The enthalpic values 
are mostly negative according to equation 1.7.  
Experimental observations showed that the chiral recognition is usually enthalpically controlled. 
A difference in Gibbs free energy between both diastereomeric complexes is essential to 
achieve enantioseparation. The principal forces are non-covalent bonds such as ionic 
interaction (electrostatic interactions between positively and negatively charged molecule 
groups), hydrogen bonding (between hydrogen-donor and hydrogen-acceptor groups), dipole-
dipole-interactions, π- π-interactions and hydrophobic interactions between lipophilic moieties 
of SA and SO. Regarding mobile phase aspects, one can say that the higher the polarity of the 
eluent the lower the strength of the electrostatic interactions. When using an aqueous mobile 
phase hydrophobic interactions come to the fore.17 
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1.3. chiral stationary phases (CSPs) 
Every class of chiral stationary phase has strengths and weaknesses in regard to selectivity, 
stability and loadability. A plethora of chiral stationary phases can be used for different 
separation problems.  Figure 1.3 gives an overview of commonly used CSPs. 
 
 
 
Figure 1.3: Overview: usual classification of CSPs 
 
1.4. chiral ionizable stationary phases 
Certain CSPs are ionizable, which will be closely discussed in the following chapters. Their 
behavior to analytes and their interaction mechanism are different to these of other CSP. In 
figure 1.4 the main representatives of ionizable CSPs are shown.  
 
Figure 1.4: Overview of chiral ionizable stationary phases 
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1.4.1. Glycopeptide-type CSPs 
The CSPs based on glycopeptide antibiotics were introduced by Armstrong18. 
In general, the used selectors have molecular weights between 600 and 2200 Daltons. The 
commercialized CSPs are based on vancomycin, teicoplanin, teicoplanin aglycon and ristocetin. 
Their structure is highly complex and they have different degrees of O-glycosylation. Armstrong 
studied the impact of chemical modification on chiral recognition capabilities of vancomycin 
and  other glycopeptides19. 
Glycopeptide antibiotics have multiple functional group assemblies that may act as potential 
enantioselective binding sites for several chiral acids and bases. The chiral recognition 
mechanism is based on the combining of hydrophobic inclusion and ionic interactions and 
strong hydrogen bonding12. 
These CSPs can be used in both reversed-phase (RP) and normal-phase (NP) conditions showing 
different enantioselectivities in each mobile phase. They also can be used in polar organic (PO) 
mode. 
It has been reported that acidic, basic, neutral and zwitterionic analytes can be 
enantioseparated with these CSPs1, 17. 
The glycopeptide phases are suitable with mass spectrometry (MS). Occasionally MS can be 
used only in RP- and PO-mode. For preparative liquid chromatography glycopeptide CSPs are 
not very suitable, because of limited sample loading capacity. Another disadvantage is that 
enantiomeric CSPs are not available. 
 
 
 14 
HO OH
HN
O
OH
N
H
O
H
N
O
O O
Cl
O
H
N
O
N
H
OH
N
H
O
CH3
H3C
H
N
CH3
O
HO
O
O
OOH3C
NH2
HOHO
OH
H3C
HO
OH
NH2
O
Cl
 
Figure 1.5: Structure of vancomycin 
 
HO O
HN
O
OH
HN
O
H
N
O
O O
Cl
H
N
O
N
H
O
HO
O
OH
HO
HO
OH
H
H
H
HO O
O
H
N O
NH2
OH
Cl
O
O
HO
HO
NH
O
H3C
HO
H
O
OH
OH
OH
H
N
R
 
Figure 1.6: Structure of teicoplanin 
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Figure 1.7: Structure of ristocetin A 
 
1.4.2. Crown Ethers 
Another important types of macrocyclic CSPs are chiral crown ethers, introduced by Cram and 
coworkers20,21. 
Crown ethers are cyclic compounds with repeating units of (-O-C2H4-). They were first 
synthesized by Peterson22. Such Crown ethers contain a hydrophobic exterior and hydrophilic 
cavities. The hydrophilic character comes from the oxygen atoms and therefore a strong affinity 
to cations is available. When used as a CSP, the ethylene-bridges of such 18-crown-6 ether are 
substituted by a chiral moiety (e.g. enantiomeric binaphtyl derivatives). Chiral 18-crown-6-ether 
selectors can be coated on reversed phase stationary phases23, 24. They are commercially 
available under the name Crownpak CR (+)® from Chiral Technologies. Further chiral crown 
ethers are 18-crown-6-ethers with tartaric acid moeities. This SO is immobilized onto silica gel 
and the corresponding CSPs is available under the trade name Chirosil RCA (+)® and Chirosil 
RCA (-)®, both from Regis. Chiral crown ether type based CSPs are illustrated in figure 1.8. 
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Figure 1.8.:  a: crownpak ®, b: crown ether Chiro Sil ® 
 
 
The chiral recognition is based on the formation of multiple hydrogen bonds (triple hydrogen 
bond) between a protonated primary amino group of the analyte and the ether-oxygens of the 
crown framework. The size and charge of the guest cation and the size of the cavity affect the 
strength of the interactions25. 
Such 18-crown-6 ethers are used in the reversed phase mode. These CSPs can be used under 
aqueous condition with addition of small amounts of organic modifier such as methanol and 
acetonitrile. The eluent has to be strongly acidic (pH between 1 and 3.5)26. 
The enantioselectivity of these chiral crown ethers for primary amines (amino acids and amino 
alcohols) is controlled by the steric factors of the substituents attached to the chiral part. 
Chirosil RCA (+)® is as well able to separate secondary amines27. Good resolution for separation 
of enantiomers could be achieved with β-blocker-type analytes 13. 
Both enantiomeric forms of the chiral crown ether are available.  
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1.4.3. Protein-based CSPs 
For enantioseparation of ionizable chiral analytes also proteins as chiral selectors can be used. 
However, only a limited number of proteins are suitable as for HPLC CSPs. Different types of 
proteins were investigated, including albumins such as human serum albumin (HSA) by 
Allenmark28 and bovine serum albumine (BSA) by Domenici29, glycoproteins such as α1-acid 
glycoprotein (AGP) by Hermansson30, ovomucoid from chicken egg whites (OMCHI) by Miwa 31 
or enzymes such as Trypsin32 or cellobiohydrolase I (CHB I)33. HSA is commercially available as 
Chiral OVM®, AGP is commercially available as chiral AGP® and OMCHI as ES-OVM®. 
There are two methods for preparation of protein-based CSPs. The protein can be physically 
adsorbed or covalently bound onto the supporting material. For supporting materials agarose, 
silica gel and polymers are used.  
HSA is structurally related to BSA and the characteristics of stereoselective binding are similar. 
On HSA-based CSPs warfarin was enantioseparated28. AGP consists of a single peptide chain. 
Information about the chiral recognition sites and mechanism of AGP is not fully discovered. 
CHB I is an acidic glycoprotein and has a binding domain connected to the rest of the enzyme. 
The core is enzymatically active. Good enantioselectivity is obtained for the separation of β-
blocking agents such as propranolol. 
Enantioseparation on protein-based CSPs was achieved for when using acidic, basic and neutral 
analytes. Hydrophobic, electrostatic and hydrogen bonding interaction are responsible for 
chiral recognition. Protein phases are always used in aqueous or hydroorganic mobile phases. 
Parameters such as pH-value of the mobile phase, type and concentration of organic modifier, 
type and strength of the buffer and temperature are important variables adjust in retention 
and enantioselectivity.  
 
Compared to other CSPs Protein-CSPs have a low loading capacity. Moreover, they show low 
efficiency because of slow desorption kinetics. Protein CSPs are not useful for preparative 
separations. A certain number of drug protein binding studies were done34. Besides, protein 
CSPs denature in organic mobile phases. Protein CSPs have to be stored in aqueous mobile 
phases. The exact mechanism of by chiral recognition is not resolved completely. 
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1.4.4. Ligand Exchange – type CSP 
Enantioselective ligand exchange chromatography (CLEC) was developed by Davankov and 
Rogozhin in 197135, 36. 
This CSP is based on rigid cyclic amino acids such as L-proline and L-hydroxyproline analoga 
which function as chelating selectors. For supporting the chelating process certain metal-ions 
such as Cu2+ or Ni2+ are added to the mobile phase. These metal-chelating functionalities are 
crucial for formation of SO-SA complexes in both SO and the analytes. CLEC invokes the 
presence of multicomponent complexes containing a central metal ion complexed by two 
chelating chiral bifunctional molecules. A diastereomeric ternary chelate complex is built 15.  
Spatial factors are decisive for the difference of the stability in the diastereomeric complex, 
which leads to different retention times. Ligand exchange is based to reversible contact of the 
selector and analyte species. Immobilized CLEC-selectors are commercially available as 
CHIRALPAK® MA, from Chiral Technology. Target analytes for CLEC-CSPs are α-amino acids, 1,2-
amino alcohols or α-hydroxy acids. 
Cu
O
N
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XX = H or OH
H2O
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O
O
O
X
H2O
S
S
S R
 
Figure 1.9.: ligand exchange phases (polystyrene support) 
 
Nowadays CLEC is not in widespread use anymore. It can only be applied on a small range of 
analytes, the toxic metal ions in the mobile phase disturb the detection and it is hard to purify 
the channels of the HPLC instruments. Moreover, the loading capacity is also limited and is not 
suited for preparative separations. 
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1.4.5. Ion Exchange-type CSPs 
A diverse chiral ion exchange-type CSPs was developed for enantioseparation of ionizable chiral 
molecules. For instance, chiral anion-exchange phases based on cinchona alkaloids are used for 
separation of chiral acids37, chiral cation-exchanger based on chiral amino sulfonic acids or 
carboxylic acids are in use for separation of bases38 . Recently, zwitterionic ion-exchangers were 
developed for the separation of chiral acids, bases and chiral zwitterionic compounds such as 
amino acids and peptides39. Commercially available ion exchange-type CSPs are Chiralpak QN-
AX® and Chiralpak QD-AX® both from Chiral Technologies.  
MeO
H
N
O
N
S
H 8 9
Si
O CH3
O
 
Figure 1.10: Chiralpak QN-AX (8S, 9R) and Chiralpak QD-AX (8R, 9S) 
 
Useful anion exchange chiral groups are primary, secondary tertiary or quaternary amino 
groups. As cation exchange groups carboxylic-, sulfonic-, sulfinic-, phosphoric-, phosphonic- or 
phosphinic acids can be used.  
The prerequisites for a successful enantioseparation are ionizable analytes under corresponding 
mobile phase pH-conditions. These CSPs have a high loading capacity and thus they are well 
suited for semipreparative and preparative separations. They are suitable for MS-hyphenation. 
There exist several types of chiral ion exchange CSPs, which are discussed in the following 
chapters. 
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1.4.5.1. ergot-alkaloid-based CSPs 
One group of chiral anion exchangers are semisynthetic ergot-alkaloid derivatives (e.g. 1-(3-
aminopropyl)-(5R, 8S, 10R)-terguide). They were introduced and intensively studied by 
Sinibaldi40.  In figure 1.11 a characteristic ergot-alkaloid-based CSP is shown. 
 
N
N
H
N N
Si
O CH3
O
S
H
H
H
 
Figure 1.11: chiral selector on silica gel 
 
Ergot-alkaloid-based CSPs have two or three asymmetric carbons, as an indole ring, a proton 
acceptor, tertiary nitrogens as electrostatic interaction sites and a sterically hindering group. 
The interaction between the analytes and the selector is mainly driven by hydrophobic and ion-
exchange effect40.  
Ergot alkaloid-based CSPs show good enantioselectivity for some carboxylic group-containing 
racemates 40, 41. 
When using reversed phase mode, where the amount of organic modifier was increased, a 
decrease in retention time was seen. These CSPs have a low molecular mass and their 
production costs are low. 
 
 
 
 
 
 
 
 
 21 
1.4.5.2. Cinchona alkaloid-based CSPs – anion exchange CSPs 
Cinchona alkaloid based CSPs were mentioned before briefly. They were applied first by     
Rosini42 and commercially available Cinchona alkaloid based CSPs were developed by 
Lämmerhofer and Lindner43.  
These chiral stationary phases are derived from QN, QD and cinchonidine. QN and QD are 
available as cheap natural sources for stereodiscriminating auxiliars (selectors, SO) and they are 
also used as resolving agents for chiral acids43. Cinchonidine has the same structure like QN but 
without the methoxy-group on the six position of the quinoline moiety. The structure of QN and 
QD is built up by the planar quinoline and a rigid quinuclidine ring, which are connected by a 
secondary methyl alcohol bridge (see figure 1.12). The molecules can be seen as a semirigid 
framework and thus as promising SO molecules43. 
In detail, QN and QD have five stereogenic centers and they differ only in absolute 
configuration at C8 and C9 and they also behave as “pseudo-enantiomerics”. QN and QD are 
diastereomers to each other, but they show an enantiomeric behavior. The stereoselectivity is 
under control of the stereogenic centers C8 and C9.  
 
N
N
MeO
OHN
N
MeO
OH(9R)
(8S) (8R)
(9S)
A B  
Figure 1.12.: A: quinine (QN), B: quinidine (QD) 
 
Different QN and QD derivatives were tested. Good results in enanatioseparation achieved new 
QN and QD carbamate-based CSPs, especially tert-butyl-carbamoylated-QN and QD CSPs. They 
were synthesized by Salvadori44 earlier and tested in anion-exchange mode by Lämmerhofer 
and Lindner43. 
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There are several sites fore intermolecular interactions like the basic aliphatic nitrogen group of 
the quinuclidine ring for electrostatic interactions (ion-pairing), the hydrogen-donor-acceptor 
site of the carbamate group for hydrogen binding and/or dipole-dipole interaction, the π-basic 
quinoline ring for intermolecular π-π interaction, the bulk quinuclidine group and the planar 
quinoline ring for steric interaction (attraction or repulsion). The tertiary amine from the 
quinuclidine forms an ion-pair with acidic analytes and thus can be classified as a weak ion 
exchanger (WAX). Intermolecular ion-pairing can be seen as a primary attractive interaction 
force. 
The alkaloid residue is anchored to the γ–mercaptopropyl silica gel by a radical reaction attack 
of the thiolgroup to the vinyl doublebound of the alkaloid. 
Comparing such QN and QD-based CSPs with each other they show similar enantioselectivity 
for the same analyte but exhibiting opposite elution orders. Experiments have also shown that 
when using QN-based WAX-CSP (D)-amino acids elute first and when using QD-based WAX-CSP 
(L)-amino acids elute first. This can be of interest when doing preparative separations or 
quantifications of enantiomeric impurities. 
In buffered hydro-organic mobile phase these CSPs have been turned out as successful for 
separation of N-derivatized α- (especially for N-3,5-dinitrobenzoyl α-amino acid derivatives), β- 
and γ−amino acids45. Acidic analytes like carboxylic, sulfonic, phosphoric and phosphonic acids 
are deprotoned to a high degree under corresponding mobile phases with certain pH-
conditions. The retention and enantioselectivity can be controlled by the concentration and 
type of buffer, the organic modifier, the type and the concentration of the counterion and by 
the temperature43. The cinchona alkaloid-based ion exchange CSPs are preferentially used in 
the polar organic or RP-mode. 
Derivatization of diverse functional groups of the cinchona alkaloids selector backbone opens a 
modification to optimize stereoselectivity43,45. In particular the carbamate function on the C9 
position can be further derivatized (e.g. to N-methyl tert-butyl carbamoylated quinine SO). 
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1.4.5.3. sulfonic acid-based CSPs – cation exchange CSPs 
To the before introduced anion exchange CSP there exist as well a contra part – the cation 
exchange CSP. 
Strong cation exchange (SCX)-CSPs were developed by Hoffmann and Lindner in 200746. 
For the SO of the SCX-CSP β-amino sulfonic acids were used, which had two chiral centers. 
(1S,2S)-2-aminocyclohexanesulfonic acid was used as it is pictured in figure. 1.13.  
 
O
Cl
Cl
O
NH
O3SY
S
 
Fig. 1.13.: SCX-CSP being of (1S, 2S)-configuration. 
 
Furthermore, the SO consists of a π-acidic aromatic moiety which can take part in π-π-inter-
actions and the existing amide group can serve for H-bonding. 
This “β-aminocyclohexanesulfonic acid” (ACHSA) SO is covalently attached to a 
chromatographic support. The anionic sulfonate group of the SO provides ion pairing with the 
chiral basic molecules which are protonated under the used mobile phase conditions. Basic 
molecules as bunitrolol, salbutamol or methoxamine were enantioseparated on these cation-
exchange CSPs. Furhtermore, the SOs have been proven to be sucessful for use in capillary 
electrophoresis 47,48 and in HPLC46. 
Chromatographic evaluation of these SCX-CSPs was carried out in a non aqueous polar organic 
mobile phase. It was observed that with increasing ACN-content selectivity and resolution 
increased. These CSPs are used in weakly acidic mobile phases. However, their application is 
defined on the separation of basic analytes. 
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1.4.5.4. Zwitterionic CSPs based on cinchona alkaloids 
The earlier proposed weak anion exchanger (WAX) based on cinchona alkaloids are limited in 
their application range. To overcome this limited application the WAX-SO has to be combined 
with an opposite charged moiety. Aminosulfonic acid-based chiral strong cation exchangers 
(SCX) fulfill this profile. With the help of a synthesis approach a chiral WAX-selector and a SCX-
selector can be fused into a promising zwitterionic selector49.  
 
 
Figure: fusion of WAX and SCX into a ZWIX 
 
The ZWIX-selector is anchored to silica gel by a radical reaction attack of the thiolgroup to the 
vinyldoublebound of the alkaloid.  
In the zwitterionic-exchange process there are two ionizable groups on the SO. These groups 
can also be characterized as an intramolecular counter-ion (IMCI). The two intramolecularly 
ionizable groups are not only responsible for ion pairing, they also act as counter-ions in the 
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ion-exchange-processes. Therefore, retention is only weakly affected by changes of the 
counter-ion concentration in the mobile phase. 
  
R
A
B
 
 
Figure 1.4.5.2.: show IMCI-effect 
 
The IMCI feature influences on the use of acidic and basic additives and allows faster separation 
with a lower amount of buffer salts in the mobile phase. Compared to the AX-type CSPs under 
the same elution conditions the retention time of the chiral acidic analytes analytes is 
shortened. This effect can be attributed to the contribution of the IMCI group. When the 
counter-ion in the mobile phase is low, the IMCI effect is a dominant factor for retention. For 
separation of zwitterionic analytes a double ion pairing process takes place50. 
The ZWIX-CSPs are normally used in polar organic mode with MeOH as bulk solvent. Addition of 
low amounts of can particulate improved enantioselectivity and increased retention. Acidic and 
basic additives in an acidic to base ratio of 2:1 has proven to be the best compromise between 
good and fast separations. 
The parentchiral anion and chiral cation exchanger are limited to analytes which carry the 
opposite charge. Combining them to ZWIX-CSPs seems to be a good choice and given broad 
application in separation ionizable chiral analytes51.  
To find out which ionizable groups are more effective, CSPs with different ionizable groups 
were tested. In doing so the cation exchange (CX) groups were varied where different 
carboxylic- and sulfonic acids were used. It turned out that with sulfonate-type CX-sites 
bounded to the C9 position of the cinchona alkaloid high enantioselective recognition for chiral 
zwitterionic analytes was dissovered50.  
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2. Results and Discussion 
2.1. Synthesis of novel - Zwitterionic Ion Exchange Chiral Stationary Phases 
(ZWIX-CSPs) 
An important focus of the diploma thesis was the synthesis of new zwitterionic chiral stationary 
phases. The idea is based on combining a chiral anion exchange part with a chiral cation 
exchange part to one zwitterionic ion exchanger. CSP 1, CSP 2 and CSP 3 were synthesized for 
the HPLC-evaluation. 
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Figure 2.1.: synthesized CSPs used for the measurements 
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Table 2.1 shows the short names, full names and the selector coverage of the used CSPs. 
 
CSP 
Number Short name Full name dimension 
coverage µmol  
[SO]g-1 [CSP] 
         
CSP 1 dimethyl-Tau-QN dimethyl-taurine-quinine 250 x 3 mm ID, 3 µm 255 
      
      
CSP 2 2-(S)-phenyl-Tau-QN 2-(S)-phenyl-taurine-quinine 
250 x 3 mm ID, 
3 µm 186 
      
      
CSP 3 2-(R)-isopropyl-Tau-QD 
2-(R)-isopropyl-taurine-
quinidine 
250 x 3 mm ID, 
3 µm 274 
      
      
CSP 4 2-(S)-isopropyl -Tau-QN 2-(S)-isopropyl-taurine-quinine 
250 x 3 mm ID, 
3 µm 203 
      
      
CSP 5 2-(S)-isobutyl-Tau-QN 2-(S)-isobutyl-taurine-quinine 
250 x 3 mm ID, 
3 µm 265 
      
      
CSP 6 ACHSA-Tau-QN 2-cyclohexyl-taurine-quinine 250 x 3 mm ID, 3 µm 232 
     
     
CSP 7 Tau-QN taurine-quinine 250 x 3 mm ID, 3 µm 190 
          
     
CSP 8 2-(R)-phenyl-Tau-QN 2-(R)-phenyl-taurine-quinine 
150 x 4 mm ID, 
5 µm 260 
     
 
Table 2.1.: names and selector coverage of all evaluated CSPs 
 
The selector coverage is in the range from 186 to 275 µmol g-1. In former experiments by our 
working group it could be shown that good enantioseparation was achieved with selector 
coverage over 200 µmol g-1 52. 
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2.1.1. Synthesis of dimethyl-Tau-QN (CSP 1) 
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Scheme 1: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b1) CS2, KOH, 100 °C, 16 
h, (b2) HCOOH, H2O2, 0°C, 16 h, (b) 1) 3, BSA, CH2Cl2, reflux, 48 h, 2) 5, CH2Cl2, r.t., 24 h, (c) AIBN, MeOH, 
reflux, 6 h. 
 
Scheme 1: quinine was converted with 4-nitrophenyl chloroformate to 5. The activated ester of 
5 was stored under N2-atmosphere because it is prone to hydrolysis. Under alkaline conditions 
the amino secondary alcohol (2-amino-2,2-dimethyl-1-propanole) reacted with CS2 and formed 
the thiazolidine-thione. The free amino group reacted first with carbon disulfide to generate N-
acyl amino alcohol hydrogen sulfate that underwent an intramolecular sulfur SN2-reaction53. 2 
was worked up with an extraction using DCM and the raw material was purified by flash 
chromatography (to separate the co-product 4,4-dimethyl-1,3-oxazolidine-2-thione). H2O2 and 
formic acid formed peroxy formic acid which oxidized 2 to the aminosulfonic acid 354. In more 
detail and according to the proposed reaction mechanism thiazolidine-2-thiones are oxidized to 
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an anthiazolidine-2-thione-1,1-dioxides cyclic sulfur compound. Then by an acid-catalyzed 
hydrolysis a 2-aminoalkanesulfinic acid was generated by removal of S=C=O. After that the 2-
amino-alkanesulfinic acid oxidized to the aminosulfonic acid with peroxy formic acid. Because 
of the exothermic reaction an ice bath was necessary to cool the reaction. Recrystallization in 
MeOH yielded pure 3. For the zwitterionic selector 6 the activated ester of quinine reacts with 
the silylated aminosulfonic acid. For solubility in the aprotic DCM, the aminosulfonic acid 3 had 
to be silylated 3. By a nucleophilic addition of the silylated aminosulfonic acid to the activated 
ester of quinine the zwitterionic selector was formed. To achieve a high yield of the selector it 
was important that the silylation of the aminosulfonic acid was completed. For removing 4-
Nitrophenol and remaining quinine and methoxycarbonate of quinine from the selector 6 a 
flash chromatography was applied. The last step c of the synthesis pathway was very delicate. 
The selector was covalently immobilized on the silica gel by a radical addition reaction on to 
thiol-modified silica via the vinyl-double bond of the QN-selector. Former experiments by the 
working group showed that the selector coverage on the endcapped 3-mercaptopropylmethyl 
modified silica gel was high when using as little solvent as possible53. 
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2.1.2. Synthesis of 2-(S)-phenyl-Tau-QN (CSP 2) 
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Scheme 2: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b1) CS2, KOH, 100 °C, 16 
h, (b2) HCOOH, H2O2, 0°C, 16 h, (b) 1) 9, BSA, CH2Cl2, reflux, 48 h, 2) 5, CH2Cl2, r.t., 24 h, (c) AIBN, MeOH, 
reflux, 6 h. 
 
Scheme 2: The procedure was the same like in 2.1.1. The sole difference was that flash 
chromatographic purification was not necessary because the co-product of 8 (4-(S)-4-phenyl-
1,3-oxazolidine-2-thione) existed in an insignificant small amount. Only the final immobilization 
step c was repeated because with the amount of AIBN reported in the literature, a selector 
loading of only 85 µmol g-1 could be achieved. Therefore the ten-times higher amount of AIBN 
was used in the second immobilization trial. The SO coverage was higher with 186 µmol g-1. The 
reasons why the coverage was low in the first trial could be that during the radical addition 
reaction some oxygen got into the apparatus through the connection-part of the mechanical 
stirrer, or for that kind of SO more AIBN was needed for proper immobilization. Further 
investigations were not carried out due to time issues. 
 31 
 
2.1.3. Synthesis of (R)-isopropyl-Tau-QD (CSP 3) 
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Scheme 3: Conditions: (a) 4-nitrophenyl chloroformate, toluene, r.t., over night, (b1) CS2, KOH, 100 °C, 16 
h, (b2) CH3COOH, H2O2, 0°C, 16 h, (b) 1) 13, BSA, CH2Cl2, reflux, 48 h, 2) 15, CH2Cl2, r.t., 24 h, (c) AIBN, 
MeOH, reflux, 6 h. 
 
Scheme 3: For synthesizing CSP3 the same synthetic steps as in the 2.1.1 were applied. Sole 
difference was that quinidine was used as starting material. The co-product ((4R)-4-(propan-2-
yl)-1,3-oxazolidine-2-thione) of 12 was removed by flash chromatography. Instead of using 
peroxy formic acid, peroxy acetic acid (reaction by H2O2 and acetic acid) was used to form the 
aminosulfonic acid. The immobilization was repeated because with the amount of AIBN 
reported in the literature, a selector loading of only 79 µmol g-1 could be achieved. Therefore a 
ten-times amount of AIBN was used like for in synthesizing CSP 2. For the repetition of the 
immobilization a new silica gel batch was used and the selector coverage was 274 µmol g-1. 
 
 32 
3. HPLC-Evaluation of ZWIX-CSPs 
An evaluation using a set of 75 amino acids was carried out. The chromatographic parameters 
which are discussed during the evaluation are the retention factor ki, the selectivity coefficient 
αij, the resolution RS and the plate number Ni. All CSPs were evaluated separately and were 
compared later with each other.  
 
3.1 Further used CSPs for Evaluation 
In our working group further CSPs were synthesized. In figure 3.1 CSP 4 to CSP 8 are pictured. 
All these CSPs are quinine-based.  
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Figure 3.1.:  further CSPs, which were used for the evaluation. 
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Continue Figure 3.1.:  further CSPs, which were used for the evaluation. 
 
 
3.2. Mobile Phase 
For the evaluation of the CSPs a polar organic mobile phase was used. A polar organic mobile 
phase consists of a polar organic solvent with basic and acidic additives, which behave like co- 
and counter-ions in ion exchange chromatography. The ion strength depends on the 
concentration of the co-iones and counter ions, on the pH-value and on the ion-charge in the 
mobile phase. Former investigations were done to ascertain the best mobile phase conditions 
for separation of basic, acidic or zwitterionic analytes. 
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The most applicable mobile phase for the use of chiral zwitterionic stationary phases turned out 
to be a polar organic solvent consisting of MeOH and ACN, for which MeOH is the bulk phase. 
Moreover the ratio of acidic to basic additives in the mobile phase was tested from 4:1 to 0.5:1 
in former studies51. Best performance of the ZWIX-mode by means of short analysis time, high 
efficiency and enantioselectivity with MeOH or low volume of ACN in MeOH. 
The studies demonstrated that the best acid-to-base-ratio regarding separation performance 
was 2:1. The type of acid and basic additive was tested. It turned out that the type of basic 
additive had no effect on the retention, but the type of acidic additives had a strong influence 
on the retention. Studies were done with acid additives like TFA, FA and HOAc. It was found out 
that enantioselectivity was best with HOAc. When using FA the resolution was the best when 
using protic MeOH and aprotic ACN as mobile phase. Using only MeOH in the mobile phase the 
hydrogen bonds are suppressed and π-π-interactions play a greater role. With adding a high 
amount of ACN the π-π-interactions are reduced and hydrogen bonding is favored. It is of 
interest how this change of interactions effects on the elution order of enantiomers. 
 
With the help of these former evaluations a mobile phase consisting of methanol as bulk phase 
and 50 mM FA and 25 MM DEA as acidic and basic additives was a compromise of high 
separation performance and proper retention times.  
In this work the composition of the bulk phase was systematically changed from 100 % MeOH 
to 50 % MeOH/ACN. With using 75 % ACN in the mobile phase limited solubility of the analytes 
in the mobile phase occurred and therefore no meaningful results were achieved. Because of 
the upcoming difficulty of measuring, basic amino acids were measured with acidic additive of 
100 mM instead of 50 mM FA in 100 % MeOH (acid/base ratio of 4/1) only during the 
characterization of CSP 2 and CSP 3.  
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3.3. Analytes 
For the evaluation of the CSPs a broad analyte set was chosen, comprising 75 racemic amino 
acids and aminosulfonic acids (including cysteic acid and homocysteic acid). Furthermore, 52 
single enantiomers were used for determination of the elution order. In three cases when (L)-
enantiomers were not available (D)-enantiomers were applied.  
The analyte set contained proteinogenic, halogenic derivatives of phenylalanine (including 
Baclofen), hydroxy AAS, β-AAS, α-alkylated (mostly methylated) AAS, N-methylated AAS, cyclic 
AAS, “Nor”-AAS and other AAS which could not be classified in the groups listed before like 
kynurenine or 1-naphtylalanine.  
The amino acids were split in aromatic (= UV-active) and aliphatic (= non-UV-active) groups and 
measured by two different instruments, where one instrument had an UV/VIS-Detector and the 
other a charged areasol detector (CAD). All amino acids were commercially available or were 
kind gifts of other working groups. (2R)-2-amino-3-sulfopropanoic acid was synthesized in 
house. α-aminosulfonic acids like 1-amino-3-methylbutane-1-sulfonic acid and 2-amino-methyl-
propane-1-sulfonic acid were removed from the analyte set because they were not stable for 
several weaks. Besides, 1,3-thiazolidine-4-carboxylic acid was removed from the analytes set. 
The used racemate and (S)-enantiomer of pyrrolidin-2-ylmethansulfonic acid was impure 
(impurity was seen after the eluted analyte). The whole set of analytes is shown in (Figure 3.2 – 
3.11). 
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Figure 3.2.: Proteinogenic AAS (exclusive glycine and cysteine), for all proteinogenic AAS the 
(L)-enantiomer is also measured 
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Figure 3.3.:  Halogen derivatives of phenylalanine (including baclofen) 
 
 
 
 
 
Figure 3.4.: Hydroxy derivatised AAS 
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Figure 3.5.: β-AAS 
 
 
Figure 3.6.: α-methylated AAS 
 
 
Figure 3.7.: N-methylated AAS 
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Figure 3.8.: Aminosulfonic acids  
 
 
Figure 3.9.: cyclic AAS 
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Figure 3.10.: “Nor”-AAS 
 
 
 
Figure 3.11.:  remaining AAS (not classified) 
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3.4. Materials and Methods for Evaluation 
The chromatographic measurements were carried out either on a 1260 series HPLC system 
from Agilent Technologies (Waldbronn, Germany) consisting of an autosampler, a binary pump 
with four channels and a variable wavelength detector (VWD) for all aromatic amino acids and 
derivatives thereof. These analytes were detected by the VWD at a wavelength of 254 nm. The 
other instrument used a 1200 series HPLC system from Agilent Technologies (Waldbronn, 
Germany) consisting of an autosampler, a binary pump with four channels and a corona 
charged aerosol detector (CAD) from ESA Bioscience, Inc. (Chelmford, USA) for all aliphatic 
amino acids and derivatives thereof. After using the columns they were washed (7 column 
volumens) and stored in MeOH. 
All measured chromatograms were edited with Chemstation B.04.03 chromatographic data 
software from Agilent Technologies and all other needed data were evaluated by Microsoft 
excel.  
 
Elution was performed in isocratic mode with a flow rate of 0.4 mL/min at (25.0 + 0.1°C). The 
void time of all columns was determined with 50 µl to 100 µl acetone in MeOH (whole volume  
1 ml) The injection volume (including determination of the void volume) was 10 µl.  
 
The analytes were dissolved either in MeOH or in a methanol-water solution. Aminosulfonic 
acids were dissolved in pure water. The analyte concentrations were  
1.0 + 0.1 mg/ml. For determination of the elution order of the enantiomers in a racemic 
mixture, a single enantiomer (in almost all samples the (L)-enantiomer) was measured, from 
which the absolute configuration was already known. 
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3.5. Comparison of ZWIX-CSPs 
The evaluation of all eight zwitterionic CSPs was arranged by a set of aromatic, aliphatic amino 
acids and aminosulfonic acids. The results are discussed in this chapter. To characterize the 
performance of each CSP the common chromatographic parameters (ki, α, RS and N) of each 
CSP were compared.  Differences in these parameters determine the separation performance 
of the CSPs.  
 
CSP 1 (dimethyl-Tau-QN) and CSP 7 (Tau-QN) are of zwitterionic character but carry no chiral 
center on the cation exchange part. 
CSP 5 (2-(S)-isobutyl-Tau-QN) has been packed badly, therefore the comparison of the plate 
number N of the columns is not meaningful.  
CSP 4 (2-(S)-isopropyl-Tau-QN) and CSP 6 (ACHSA-Tau-QN) were compared to each other. CSP 6 
is a “Benchmark CSP” with the best results for separation of amino acids in former studies50, 51. 
Moreover, CSP 1 (dimethyl-Tau-QN) and CSP 7 (Tau-QN) were compared to determine if a chiral 
center at the SCX-part or just a steric hindering group is crucial for pronounced 
enantioselectivity towards zwitterionic analytes. 
CSP 2 (2-(S)-phenyl-Tau-QN) and CSP 8 (2-(R)-phenyl-Tau-QN) were compared to determine if 
elution order switches when changing the configuration of the chiral center at the SCX-part. 
CSP 3 (2-(R)-isopropyl-Tau-QD) and CSP 4 (2-(S)-isopropyl-Tau-QN) were compared to each 
other to discuss the elution order of the enantiomers when switching from QN to QD based 
selectors.  
The influence of the SCX-part side chains particular CSPs (CSP 2, 4, 5 and 6) were compared to 
each other. 
 
Finally to mention, the measurement of the basic and acidic amino acids was difficult and did 
not give good results. The used mobile phase-conditions are not the best for separating such 
amino acids.  
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Retention Factor ki 
The retention factor ki is calculated from the void time t0 of the column and of the retention 
time ti of the analyte.  
        [3.1] 
 
The retention factor ki specifies the binding strength between the chiral selector attached on 
the silica gel and the selectant (analytes). When the retentions factor ki becomes larger, the 
stronger the interaction between selector and analyte will be. 
 
Selectivity coefficient/ separation factor α 
The separation factor α describes the selectivity and gives information about the capability of a 
chromatographic system. Calculated by dividing of the retention factors of the second eluted 
enantiomer (k2) through the first (k1) eluted enantiomer gives α.   
      [3.2] 
 
Different retention factors lead to α–values over 1.00.  An α-value of 1.00 means that there is 
no (enantio)separation of the two enantiomers. High α-values allow baseline separation at the 
baseline and show good application for preparative separations. 
 
Resolution RS     
The resolution is one of the significant parameters and shows the quality of a separation. 
The resolution RS depends on the retention factor ki, on the selectivity coefficient α and of the 
plate number N. Baseline separation occurs when RS-value is over 1.50. Values between 1.00 
and 1.50 mean partial separation. High resolution values are necessary for preparative 
chromatography applications. 
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Theoretical plate number N 
The plate number N provides information about column performance. Furthermore, N provides 
information about the packing quality of a column and the selector coverage on the stationary 
phase. Low N-values are in many cases sign of peak tailing. 
The peak shape can be described by the asymmetry factor AS = a/b. The asymmetric factor is 
defined as the distance b (distance from the peak center line to the back slope) divided by the 
distance a (distance from the peak center line to the front slope). These distances are made at 
10 % of the maximum peak height. When the value of the asymmetric factor is near 1, the peak 
is almost symmetric, when the value is over 1 the peak is tailing, when the value is under 1 peak 
fronting occurs. 
 
Figure 3.1.: Asymmetric factor 
Retention studies 
As it is seen in table 3.1 all zwitterionic stationary phases have different selector coverage.  
The difference in the selector loading from the lowest to the highest coverage accounts for  
88 µmol g-1. Former investigation in the working group showed that the height of selector 
loading influence on the amount of the interactions between the selector and the selectand 
and therefore a increasing of the retention time52. 
 
In Table 3.1 the average of the retention factor k1 of aromatic and aliphatic amino acids and 
aminosulfonic acids of all CSPs were also compared to each other. 100 % MeOH with 50 mM FA 
and 25 mM DEA were used as mobile phase. 
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Table 3.1.: average k1-values of certain zwitterionic analyte groups 
 
When considering the k1-values, it can be interpreted that the average retention in CSP 1 is the 
lowest, following by the retention factors of CSP 2 and CSP 7. CSP 6 shows stronger retention 
towards almost all analytes.  
All CSPs differ in the SCX-part of the selector. It is of interest how the different SCX-part of each 
CSP affects the interaction between analyte and selector and also the retention of the analytes. 
Investigation on different CSPs and different mobile phases was done by our working group51 
before. It was discovered that retention of zwitterionic analytes increased with increasing ACN 
in the mobile phase. On the other hand the presence of a higher ACN amount leads to decrease 
of enantioselectivity-values and resolution-values in many cases. Besides, using a higher 
amount of aprotic ACN a degradation of peak efficiency could be observed and thus, baseline 
separation could be more difficult to achieve.  
Retention studies with all three mobile phases (pure MeOH, MeOH with 25 % ACN and MeOH 
with 50 % ACN) were realized with CSP 6 (whole analyte set), CSP 1, CSP 5 (both aromatic 
analytes only) and with CSP 4 (aliphatic analytes only). For the majority of these analytes it was 
observed that α-values and RS-values were increasing. The opposite behavior was also observed 
at certain analytes, like α-methyl-DOPA (as displayed in the figure 3.1 and 3.2). 
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Figure 3.1.: trend of α-values of certain zwitterionic analytes on CSP 6 
 
 
Figure 3.2.:  trend of resolution-values of certain zwitterionic analytes on CSP 6 
 
 
It was clearly visible that the retention factor k1 increased with higher amount of ACN in the 
mobile phase. The k1-values increased up to 97 % in average (comparing data of all analytes 
measured on CSP 1 to CSP 7) when using 50 % ACN in mobile phase compared to 100 % MeOH. 
In figure 3.3 and figure 3.4 changes of k1-values and α-values are shown. 
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Figure 3.3. α-values and k1-values of β-phenylalanine, Nor-leucine and  
β-neopentylglycine with pure MeOH, 25 % and 50 % ACN in MeOH on CSP 6 
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Figure 3.4. α-values and k1-values of trans-4-hydroxyproline, tryptophan and  
α-methyl-DOPA with in MeOH, 25 % and 50 % ACN in MeOH on CSP 6 
 
Using these CSPs it was observed that the separation factor α and the resolution RS increased 
with higher amount of ACN depending on the analytes. For the majority of the analytes the 
values of enantioselectivity and resolution increased with higher ACN-amount, as it was 
pictured in figure 3.3. The separation factor decreased with higher ACN-content as pictured in 
figure 3.4. The retention factors of all analytes were increasing with higher ACN-amount. The α-
values increased with increasing the ACN-amount in the mobile phase with the exception that 
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the α-values of tryptophan and tryptophan derivatives and of many α-methylated amino acids 
decreased.  
 
In figure 3.5 and 3.6 changes of the parameters RS and N2 were pictured, where in figure 3.5 an 
increase of RS with higher ACN amount and in figure 3.6 a decrease of RS with higher ACN 
amount was seen. The values of the plate number N2 of the second eluted enantiomer seemed 
to become smaller at higher amount of aprotic solution.  
The resulting peaks are not symmetric. A tailing under every mobile phase condition could be 
observed, where in 50/50 MeOH/ACN the peak-tailing was the greatest.  
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Figure 3.5. resolution-values and N2-values of β-phenylalanine, Nor-leucine and  
β-Neopentylglycine in pure MeOH, 25 % and 50 % ACN in MeOH on CSP 6 
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Figure 3.6. resolution-values and N2-values of trans-4-hydroxyproline, tryptophan and  
α-methyl-DOPA and pure MeOH, 25 % and 50 % ACN in MeOH on CSP 6 
 
Figure 3.7 depicts three chromatograms of tert-leucine under three different mobile phase 
conditions. The two enantiomeric peaks of tert-leucine were better separated and higher 
retained with higher ACN amount in the mobile phase. In contrary, the peaks show stronger 
tailing. The peaks became smaller and broader. By calculating the asymmetry factor it was 
confirmed that the tailing became stronger with higher ACN-amount in the mobile phase. 
 
 
Figure 3.7. HPLC enantiomer separations of tert-leucine on ACHSA-Tau-QN (CSP 6) with 100 % MeOH, 25 
% ACN and 50 % ACN in the mobile phase (t0=3.40 min) 
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Figure 3.8 shows separation of 5-HTP. The selectivity and resolution decreased with increasing 
the ACN amount. At 50 % ACN in the mobile phase there was no baseline separation. The 
asymmetric factor became smaller whicht indicated that tailing was smaller in mobile phase 
with higher amount of aprotic solvent. 
 
Figure 3.8. HPLC enantiomer separations of 5-HTP on ACHSA-Tau-QN (CSP 6) with 100 % MeOH, 25 % 
ACN and 50 % ACN in the mobile phase (t0=3.40 min) 
 
After evaluating the first CSPs with all three mobile phase conditions (100 % MeOH, 25 % ACN 
and 50 % ACN) it was seen that for determining changes in selectivity and resolution only two 
mobile phases (100 % MeOH and 50 % ACN) were necessary and the mobile phase with 25 % 
ACN could be omitted. 
 
Comparing all data of the analytes with 100 % MeOH and 50 % ACN in MeOH, the strongest 
decrease of enantioselectivity was seen on CSP 3 (47 % of the analytes), the less on CSP 6 (25 % 
of the analytes). For aromatic analytes the greatest decrease of separation factor α was on CSP 
7 (79 % of the analytes). When comparing all α-values and RS-values of all zwitterionic analytes 
used on all CSPs with all mobile phases, there were 60 % of all α-values and 58 % of all RS-values 
increased with increasing ACN-amount. At 10 % of all analytes the α-values increased where RS-
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values decreased because of worse peak shapes. At 8 % of all analytes the RS-values increased 
where the α-value decreased. 
 
To sum up, resolution-values were increasing on average with higher ACN-amount. For many 
analytes the separation factor α on diverse CSPs was increasing with higher ACN content as 
well. Nevertheless, the opposite behavior occurred on all CSPs for certain analytes like 
tryptophan and tryptophan derivatives. Using CSP 3 had the lowest decrease in resolution while 
CSP 6 had the most. 
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3.6. ACHSA-Tau-QN (CSP 6) vs. 2-(S)-isopropyl-Tau-QN (CSP 4) 
 
Si
O
O
S
N
O
H
N
N
O O
(9R)
(8S)
SO3
CSP 6
(2S)
(1S)
H
 
Si
O
O
S
N
O N
SO3
N
O O
(9R)
(8S)
CSP 4
H (S)
 
 
Previous studies revealed that CSP 6 and CSP 4 showed best results in enantioselectivity and 
resolution. Both CSPs are of the quinine-type. The selectors of these two CSPs differ only in 
their side chain of the SCX-moiety. CSP 6 consists of a cyclohexane moiety with absolute 
configurations (1S) and (2S) at the aminosulfonic acid part. CSP 4 has an isopropyl group with a 
(S)-configuration. The cyclohexyane moiety is a larger and more spatially demanding group than 
the isopropyl moiety and is also more rigid. 
 
β-AAS 
In former research of the working group, it was confirmed that β-amino acid enantiomers were 
strongly retained and partly better enantioseparated than α-amino acids55. Comparison of 
enantioselectivity values between CSP 6 and 4 revealed higher α-values for CSP 4. Of all β-AAS 
nipecotic acid had the best values. With 50 % ACN in the mobile phase all β-AAS were baseline 
separated on both CSPs. 
 
VS. 
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    CSP 6     CSP 4     CSP 6     CSP 4   
    100 % MeOH  100 % MeOH  50 % ACN  50 % ACN 
β-AAS EO α RS EO α RS EO α RS EO α RS 
Nipe R-S 1.99 4.08 R-S 2.23 5.69 R-S 2.40 5.74 R-S 2.89 10.03 
β-Leu  n.d. 1.06 0.64  n.d. 1.06 0.56  n.d. 1.23 2.91  n.d. 1.23 3.57 
β-Neopentylgly  n.d. 1.33 2.00  n.d. 1.35 2.59  n.d. 1.50 3.19  n.d. 1.53 4.39 
β-Phe  n.d. 1.11 1.20  n.d. 1.15 1.95  n.d. 1.26 2.67  n.d. 1.31 5.79 
β-homo-Phe  n.d. 1.03 0.52  n.d. 1.00 0.00  n.d. 1.10 1.92  n.d. 1.11 1.84 
Average values   1.30 1.69   1.36 2.16   1.50 3.29   1.62 5.12 
 
Table 3.2.: β-AAS measured on CSP 4 and 6  
α-methylated AAS 
Several zwitterionic CSP were able to enantioseparate α-methylate amino acids in former 
studies49.  
 CSP 4 and 6 separated only a part of α-methylated AAS enantiomers. All used α-methylated 
AAS could be partially separated on CSP 4 using 100 % MeOH, but only three analytes - all are 
aromatic - were baseline separated. The best α-value and RS-value in all two mobile phases had 
α-methylated tryptophan. The elution order of α-methylated tyrosine changed on both CSPs 
when using higher ACN amount in the mobile phase. In pure MeOH the aromatic α-methylated 
amino acids were better separated on both CSPs. 
 
  CSP 6 CSP 4 CSP 6 CSP 4 
    100 % MeOH   100 % MeOH   50 % ACN    50 % ACN  
α -methylated AAS EO α RS EO α RS EO α RS EO α RS 
α-Me-Leu  n.d. 1.00 0.00 n.d.  1.08 0.49  n.d. 1.12 1.00  n.d. 1.18 1.32 
α-Me-Val  n.d. 1.00 0.00 n.d.  1.02 0.16  n.d. 1.00 0.00  n.d. 1.00 0.00 
α-Me-Ser  n.d. 1.13 0.79 n.d.  1.11 0.59  n.d. 1.11 0.85  n.d. 1.08 0.54 
α-Me-Phe   n.d. 1.13 0.49 D-L 1.18 0.59  n.d. 1.00 0.00  n.d. 1.00 0.00 
α-Me-Tyr D-L 1.17 0.88 D-L 1.14 0.67 L-D 1.07 0.53 L-D 1.07 0.54 
α-Me-m Tyr  n.d. 1.42 2.70 n.d.  1.42 2.54 n.d.  1.29 2.03 n.d. 1.31 2.22 
α-Me-DOPA D-L 1.46 3.18 D-L 1.52 2.52 D-L 1.22 1.62 D-L 1.29 1.68 
Α-Me-Trp  n.d. 3.40 20.61 n.d.  3.56 20.51 n.d.  2.14 13.28 n.d.  2.07 13.31 
Average values   1.46 3.58   1.50 3.51   1.24 2.41   1.25 2.45 
 
Table 3.3.: α –methylated AAS measured on CSP 4 and 6 
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Aminosulfonic AAS 
On CSP 6 the aminosulfonic acids were stronger retained. Cysteic acid and homocysteic acid 
had larger retention factors than the other analytes and also showed a strong peak tailing. On 
both CSPs these two aminosulfonic acids could not be enantioseparated. The analytes 2-tert-
butyltaurine, 2-ethyltaurine, 2-isopropyltaurine and 2-phenyltaurine were baseline separated 
on both CSPs with both mobile phase conditions. The elution order did not change with higher 
ACN amount. 
 
  CSP 6 CSP 4 CSP 6 CSP 4 
    100 % MeOH   100 % MeOH    50 % ACN    50 % ACN  
aminosulfonic acids EO α RS EO α RS EO α RS EO α RS 
Homocysteic acid n.d. 1.00 0.00 n.d.  1.00 0.00 n.d. 1.00 0.00 n.d. 1.11 0.60 
Cysteic acid n.d. 1.00 0.00 L-D 1.11 0.60 n.d. 1.00 0.00 n.d. 1.13 0.49 
 trans-2-ACHSA n.d. 1.05 0.48  n.d. 1.09 0.60 n.d. 1.08 0.55 n.d. 1.05 0.39 
 cis-2-ACHSA n.d. 1.37 1.85  n.d. 1.26 1.18 n.d. 1.37 1.47 n.d. 1.18 0.68 
cis-3-ACHSA n.d. 1.11 0.66  n.d. 1.16 0.87 n.d. 1.03 0.28 n.d. 1.04 0.29 
 trans-2-Me-2-ACHSA n.d. 1.10 1.33  n.d. 1.49 5.31 n.d. 1.00 0.00 n.d. 1.19 3.83 
2-tert-Bu-Tau R-S 2.46 5.77 R-S 2.79 6.47 R-S 2.52 4.28 R-S 2.62 4.97 
2-Et-Tau R-S 1.39 2.33 R-S 1.52 2.48 R-S 1.43 1.96 R-S 1.54 2.23 
2-Me-Tau R-S 1.08 0.56 R-S 1.16 0.83 R-S 1.08 0.51 R-S 1.17 0.69 
Pro-Me-SO3H R-S 1.21 1.04 R-S 1.34 1.35 /// 2.10 7.19 R-S 1.22 0.73 
2-isopropyl-Tau D-L 1.47 4.41 D-L 1.63 2.99 D-L 1.53 3.99 D-L 1.67 2.58 
2-phenyl-Tau D-L 1.21 2.57 D-L 1.37 2.75 D-L 1.16 1.70 D-L 1.31 1.82 
Average values   1.29 1.75   1.41 2.12   1.36 1.83   1.35 1.61 
 
Table 3.4.: aminosulfonic acids measured on CSP 4 and 6 
 
Aromatic AAS  
Almost all aromatic amino acids could be enantioseparated. A majority of the analytes was 
baseline separated where the most were baseline separated with a mobile phase of 50 % A CN 
on CSP 4. A change of elution order was only seen for α-methylated tyrosine when measuring 
with higher ACN amount in the mobile phase. On average the α-values and the RS-values 
decreased when using 50/50 MeOH/ACN mobile phase. 
 
 
 55 
 
 
 
  CSP 6 CSP 4 CSP 6 CSP 4 
    100 % MeOH   100 % MeOH   50 % ACN   50 % ACN  
aromatic amino 
acids EO α RS EO α RS EO α RS EO α RS 
Phe L-D 1.15 0.96 L-D 1.16 1.06 L-D 1.21 1.56 L-D 1.19 1.17 
p-F-Phe L-D 1.13 1.31 L-D 1.11 1.10 L-D 1.19 2.03 L-D 1.18 2.13 
p-Cl-Phe L-D 1.14 1.47 L-D 1.12 1.48 L-D 1.19 1.29 L-D 1.20 2.49 
p-Br-Phe n.d. 1.14 1.80 n.d. 1.13 1.62 n.d. 1.18 2.12 n.d. 1.21 2.66 
o-F-Phe n.d. 1.16 1.81 n.d. 1.16 1.14 n.d. 1.21 2.80 n.d. 1.21 1.63 
β-Phe n.d. 1.11 1.20 n.d. 1.15 1.95 n.d. 1.26 2.67 n.d. 1.31 5.79 
β-homo-Phe n.d. 1.03 0.52 n.d. 1.00 0.00 n.d. 1.10 1.92 n.d. 1.11 1.84 
α-Me-Phe n.d. 1.13 0.49 D-L 1.18 0.59 n.d. 1.00 0.00 n.d. 1.00 0.00 
p-Amino-Phe n.d. 1.16 0.79 n.d. 1.14 0.77 n.d. 1.27 1.15 n.d. 1.23 1.14 
DOPA L-D 1.07 0.59 n.d. 1.00 0.00 L-D 1.16 0.83 L-D 1.07 0.37 
α-Me-DOPA D-L 1.46 3.18 D-L 1.52 2.52 D-L 1.22 1.62 D-L 1.29 1.68 
                   
Tyr L-D 1.15 1.06 L-D 1.13 0.86 L-D 1.30 1.78 L-D 1.24 1.61 
m-Tyr n.d.  1.09 0.73 n.d. 1.06 0.46 n.d.  1.13 0.96 n.d. 1.08 0.59 
α-Me-Tyr D-L 1.17 0.88 D-L 1.14 0.67 L-D 1.07 0.53 L-D 1.07 0.54 
α-Me-m Tyr n.d.  1.42 2.70 n.d. 1.42 2.54 n.d.  1.29 2.03 n.d. 1.31 2.22 
OMe-Tyr L-D 1.14 1.20 L-D 1.15 1.36 L-D 1.17 1.21 L-D 1.19 1.72 
                   
Trp D-L 1.57 7.11 D-L 1.61 7.62 D-L 1.25 3.14 D-L 1.26 3.21 
α-Me-Trp  n.d. 3.40 20.61 n.d. 3.56 20.51  n.d. 2.14 13.28 n.d. 2.07 13.31 
1-Me-Trp D-L 1.33 4.49 D-L 1.36 4.98 D-L 1.10 1.29 D-L 1.12 1.64 
5-HTP D-L 1.38 4.92 D-L 1.43 5.23 D-L 1.10 1.15 D-L 1.13 1.32 
                   
Baclofen n.d.  1.25 3.35 n.d. 1.28 5.43  n.d. 1.32 3.99 n.d. 1.34 6.99 
Phenylglycine L-D 1.06 0.77 L-D 1.04 0.54 L-D 1.09 1.26 n.d. 1.00 0.00 
Kynurenine L-D 1.24 2.63 L-D 1.10 1.31 L-D 1.23 1.93 L-D 1.12 1.61 
1-Naphtylalanine L-D 1.14 1.50 L-D 1.12 1.68 L-D 1.16 1.48 L-D 1.14 1.74 
Tic S-R 1.33 2.30 S-R 1.32 2.20 S-R 1.29 1.94 S-R 1.27 2.08 
Average values   1.29 2.73   1.30 2.70   1.22 2.16   1.21 2.38 
 
Table 3.5.: aromatic amino acids measured on CSP 4 and 6 
 
Proteinogenic AAS 
Independent of using one of the two CSP in addition with one of the mobile phase conditions 
the (L)-enantiomers eluted first expect from the two acidic amino acids aspartic acid and 
glutamic acid. Proline-enantiomers were best separated. With 100 % MeOH using CSP 4 serine 
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could be partial separated. On CSP 6 the majority of these amino acids could be baseline 
separated. 
 
  CSP 6 CSP 4 CSP 6 CSP 4 
    100 % MeOH    100 % MeOH    50 % ACN    50 % ACN  
proteinogenic 
AAS EO α RS EO α RS EO α RS EO α RS 
Ala L-D 1.15 0.50 L-D 1.13 0.48 L-D 1.17 0.61 L-D 1.11 0.60 
Val L-D 1.26 1.74 L-D 1.22 1.51 L-D 1.33 2.42 L-D 1.22 1.94 
Leu L-D 1.22 1.72 L-D 1.22 1.63 L-D 1.27 2.21 L-D 1.19 2.03 
Ser  1.00 0.00 L-D 1.09 0.56  1.00 0.00  1.00 0.00 
Thr L-D 1.23 1.33 L-D 1.25 1.31 L-D 1.30 2.02 L-D 1.30 1.46 
Phe L-D 1.15 0.96 L-D 1.16 1.06 L-D 1.21 1.56 L-D 1.19 1.17 
Tyr L-D 1.15 1.06 L-D 1.13 0.86 L-D 1.30 1.78 L-D 1.24 1.61 
Trp D-L 1.57 7.11 D-L 1.61 7.62 D-L 1.25 3.14 D-L 1.26 3.21 
Ile L-D 1.26 2.01 L-D 1.24 2.02 L-D 1.33 2.44 L-D 1.24 2.58 
Met L-D 1.14 1.19 L-D 1.10 0.96 L-D 1.17 1.20 L-D 1.11 1.04 
Lys L-D 1.16 1.04 L-D 1.18 2.27 n.d. L-D 1.00 0.00 
Pro L-D 1.57 4.01 L-D 1.56 4.30 L-D 1.86 5.85 L-D 1.94 5.96 
Asn  1.00 0.00 L-D 1.20 1.00 L-D 1.33 1.56  1.00 0.00 
Gln L-D 1.16 0.69   1.00 0.00 L-D 1.27 0.93 n.d.  1.26 1.38 
Asp  1.00 0.00 D-L 1.05 0.33  1.00 0.00  1.00 0.00 
Glu  1.00 0.00 D-L 1.10 0.59 D-L 1.15 1.02 n.d.  1.15 0.66 
Arg n.d. 1.07 0.50 n.d.  2.37 1.38 n.d. n.d. 
His   1.00 0.00 L-D 1.40 1.59 n.d.  n.d.  1.58 0.87 
Average values  1.15 0.98  1.27 1.33  1.27 1.69  1.22 1.32 
 
Table 3.6.: proteinogenic acids measured on CSP 4 and 6 
 
CSP 6 achieved better results of average α-values and RS-values. Besides, the retention-value 
was greater for almost all analytes when using CSP 6. For phenylalanine and all phenylalanine 
derivatives the retention factors were nearly (+ 0.05) the same. 
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Figure 3.9.: ratio of baseline separation, partial separated and not separated analytes  
 
To sum up, in many cases the results with 2-(S)-isopropyl-Tau-QN are the same with ACHSA-
Tau-QN. When using 100 % MeOH the same set of analytes could be baseline separated, with 
higher aprotic amount 2-(S)-isopropyl-Tau-QN could baseline separate two analytes more. 
CSP 4 seems to be a competitive CSP to CSP 6 regarding to in enantioseparation of amino acids. 
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3.7. Tau-QN (CSP 7) vs. Dimethyl-Tau-QN (CSP 1) 
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CSP 1 and CSP 7 are similar. They both are according to their structure based on quinine. The 
sole difference is in the SCX-part of the selectors. Where Tau-QN (CSP 7) has no side chain, CSP 
1 has a dimethyl-group. Compared to all other zwitterionic CSPs, CSP 1 and CSP 7 do not carry 
chiral information on the cation-exchange site. 
Is a chiral center on the SCX-part or just a steric hindering group for amino acid-
enantioseparation necessary or are stereogenic centers in the QN sufficient?   
It was compared how many analytes were enantioseparated on each CSP. It was distinguished 
between not separated, partly separated (0.1 < RS < 1.5) and baseline separated (RS > 1.5) 
There were a small number of analytes which are baseline separated. CSP 1 did not separate 
the majority of analytes at any mobile phase condition. When using CSP 7 with 50 % ACN in the 
mobile phase the majority of the analytes (53 %) are at least partial separated, where 20 % of 
the analytes are baseline separated. 
VS. 
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Figure 3.10.: ratio of baseline separation, partial separated and not separated analytes  
 
According to the data (appendix) all tryptophan and tryptophan derivatives were baseline 
separated on CSP 1 and 7 on both mobile phases. 
The dimethyl-group does not strongly affect the retention. The retention factors between the 
two CSPs were almost the same when using 100 % MeOH. When using 50 % ACN in the mobile 
phase the analytes’ retention factors were larger on CSP 1.  
 
To summarize, using both CSPs with 100 % MeOH more than 50 % of the analytes could not be 
enantioseparated. Under the same mobile phase condition CSP 7 could baseline separate 8 % 
more analytes than CSP 1 with a steric hindering group on the SCX-part. When changing the 
mobile phase to more aprotic character the amount of separated analytes kept the same. In 
contrary, on CSP 7 the number of separated analytes increased.  
The results showed that a stereogenic center on the SCX-part is necessary for 
enantioseparation and that a sole steric hindering group is not sufficient for braod 
enantioselectivity towards amino acids.  
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3.8.: 2-(S)-phenyl-Tau-QN (CSP 2) vs. 2-(R)-phenyl-Tau-QN (CSP 8) 
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CSP 2 and CSP 8 are both based on QN and have the same phenyl-group on position 2 of the 
SCX-part, only the chiral center is of opposite absolute configuration. The phenyl-group in CSP 2 
has the (S)-configuration and in CSP 8 the group is in (R)-configuration.  
The difference in selector coverage between these two CSPs makes 74 µmol g-1.For the reason 
that the column-dimensions of CSP 2 and 8 are different, only the selectivity values can be 
compared with each other to give valuable information (table 3.1). On CSP 8 only a selected 
number of amino acids from the set were measured (almost just the analytes where the single 
enantiomer was available and thus the elution order could be determined). 
Both CSPs inhibit a stereogenic center at the SCX-moiety. How does the chiral information on 
the SCX-part affect the enantioseparation and does a change of configuration in the SCX-part 
lead to a change of elution order or does the change only depend from QN/QD in general? 
 
VS. 
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  CSP 2 CSP 8 
  100 % MeOH 100 % MeOH 
Analyt EO α EO α 
Ala  1.10  1.00 
Val L-D 1.15  1.00 
Leu L-D 1.15  1.00 
Thr L-D 1.18  1.00 
Ile L-D 1.16  1.00 
Met L-D 1.06  1.00 
Lys L-D 1.12 L-D 1.15 
Pro L-D 1.32 L-D 1.07 
Asn  1.15  1.08 
Asp D-L 1.04 L-D 1.05 
Arg  1.06 L-D 1.10 
trans-4-OH-Pro L-D 2.84 L-D 1.53 
cis-4-OH-Pro  1.12 D-L 1.33 
Nor-Leu L-D 1.18  1.00 
Nor-Val L-D 1.17  1.00 
Nipe R-S 1.67 S-R 1.09 
Pipe L-D 1.11  1.00 
allo-Ile L-D 1.17  1.00 
Neopentylgly L-D 1.29  1.00 
tert-Leu L-D 1.26  1.00 
2-tBu-Tau R-S 2.22  1.00 
2-Et-Tau R-S 1.55  1.00 
2-Me-Tau R-S 1.19  1.00 
Pro-Me-sulfonic acid S-R 1.87  1.00 
2-isopropyl-Tau D-L 1.57  1.00 
2-phenyl-Tau D-L 1.34 D-L 1.20 
          
 
Table 3.7.: elution order and resolution-values using100 % MeOH 
 
With 2-(R)-phenyl-Tau-QN (CSP 2) a great amount of aliphatic amino acids could be separated, 
whereas on 2-(S)-phenlyl-Tau-QN (CSP 8) in many cases no separation occurred (table 3.7). CSP 
8 showed similar separation profile than Tau-QN (CSP 1). For certain analytes (aspartic acid and 
nipecotic acid) a change in elution order was observed. 
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It seems that the (R)-configuration of the side chain in the SCX-part does not favorer 
enantioseparation of zwitterionjic analytes compared to the (S)-configuration.  
 The measurement of the aliphatic analytes was only done with 100 % MeOH in the mobile 
phase. In contrast, the aromatic analytes could be separated on CSP 8. In table 3.8 and 3.9 the 
data of the aromatic analytes are shown.  
  CSP 2 CSP 8 
  100 % MeOH 100 % MeOH 
Analyt EO α EO α 
Phe   1.00  1.00 
Trp D-L 1.81 D-L 2.14 
5-HTP D-L 1.88 D-L 1.86 
α-Me-Tyr D-L 1.20 D-L 1.23 
α-Me-DOPA D-L 1.50 D-L 1.34 
1-Me-Trp D-L 1.42 D-L 1.26 
Kynurenine L-D 1.06  1.00 
Tic S-R 1.21 S-R 1.13 
Average values         
 
Table 3.8.: elution order and α-values using 100 % MeOH 
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  CSP 2 CSP 8 
  50 /50 MeOH/ACN 50 /50 MeOH/ACN 
Analyt EO α EO α 
Phe L-D 1.05   1.00 
Trp D-L 1.45 D-L 1.92 
5-HTP D-L 1.49 D-L 1.58 
α-Me-Tyr  1.00 D-L 1.08 
α-Me-DOPA D-L 1.24 D-L 1.12 
1-Me-Trp D-L 1.20 D-L 1.14 
Kynurenine  1.00   1.00 
Tic S-R 1.19 S-R 1.12 
Average values         
 
Table 3.9.: elution order and resolution-values using 50 /50 MeOH/ACN 
 
 
Figure 3.11.: α-values of aromatic analytes with 100 % MeOH 
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Figure 3.12.: α-values of aromatic analytes with 100 % MeOH 
  
The α-values of the majority of the aromatic analytes were smaller on 2-(S)-Phenyl-Tau-QN (CSP 
8). Only tryptophan and 5-HTP clearly showed better separation on CSP 8. 
When using the aromatic analytes as well no change of elution order was seen. 
A chiral information at the SCX-part of a selector compared to selectors without a stereogenic 
centre at the SCX-part supports enantioseparation. The 2-(S)-configuration of the phenyl-
moiety on the SCX-part combined with the QN on the WAX-part of the selector leads to 
enantioseparation in many cases. On the other hand, the 2-(R)-configuration of the phenyl-
moiety does not seem to support the separation of enantiomers. It seems that this 
configuration combined with the QN-moiety is badly suited for enantioseparation.  
Besides, with changing only the configuration in the SCX-part no effective change of elution 
orders occurred. Only for two aliphatic amino acids this phenomenon could be observed. 
Thus, the change of configuration only in the SCX-part only is not sufficient for the change of 
elution order of the zwitterionic analytes. 
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3.9. 2-(R)-isopropyl-Tau-QD (CSP 3)  vs. 2-(S)-isopropyl-Tau-QN (CSP 4) 
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It is well-established by former studies44 that quinine and quinidine-based selectors are 
behaving as pseudo-enantiomers to each other and showing similar enantioselectivites for 
specific analytes but with a switching of the elution order of the enantiomers.  
2-(S)-isopropyl-Tau-QN (CSP 4) is the pseudoenantiomeric contra-part of 2-(R)-isopropyl-Tau-
QD (CSP 3). The comparison of these two CSP is important for the evaluation. It is of interest if 
which part of the selector is responsible for the change of the elution order. 
CSP 3 is QD-based with the chiral SCX-side chain in (R)-configuration and CSP 4 has a QN-moiety 
with the chiral SCX-side chain in the (S)-configuration. 
It is interesting if that phenomenon of switching elution orders of enantiomers occurs when 
comparing these two zwitterionic CSPs. 
In the following tables 3.10 – 3.14 the chromatographic parameter are shown. 
 
 
 
 
VS. 
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β-AAS  
β-AAS were baseline separated, when using 100 % MeOH. Using 50 % aprotic ACN in the mobile 
phase all β-AAS were baseline separated where nipecotic acid gave exceptionally high RS-values. 
Selectivity- and resolution-values increased with increasing amount of ACN. 
 
  CSP 3 CSP 4 CSP 3 CSP 4 
  100 % MeOH 100 % MeOH 50 % ACN 50 % ACN 
 β-AAS k1 α RS k1 α RS k1 α RS k1 α RS 
Nipe 1.23 2.52 9.02 2.22 2.23 5.69 2.72 2.99 11.80 3.82 2.89 10.03 
 β-Leu 2.06 1.11 1.35 2.40 1.06 0.56 5.05 1.33 4.66 5.13 1.23 3.57 
 β-Neopentylgly 1.88 1.36 3.40 2.01 1.35 2.59 4.29 1.59 6.18 3.98 1.53 4.39 
β-Phe 0.82 1.26 2.12 1.17 1.15 1.95 5.89 1.56 4.32 7.09 1.31 5.79 
 β-homo-Phe 2.36 1.00 0.00 3.22 1.00 0.00 7.05 1.18 3.20 7.77 1.11 1.84 
Average values   1.45 3.18   1.36 2.16   1.73 6.03   1.62 5.12 
 
Table 3.10.: β-AAS measured on CSP 3 and 4 
α-methylated AAS  
With higher aprotic content in mobile phase the selectivity-values decreased. On both CSPs α-
methylated tryptophan was separated best. On average, aliphatic α-methylated AAS had 
smaller α-values than the aromatic ones. It is to mention that α-methyl-meta-tyrosine could be 
better separated than α-methyl-tyrosine. 
 
  CSP 3 CSP 4 CSP 3 CSP 4 
  100 % MeOH 100 % MeOH 50 % ACN 50 % ACN 
α-methylated AAS k1 α RS k1 α RS k1 α RS k1 α RS 
α-Me-Leu 0.31 1.00 0.00 0.44 1.08 0.49 1.32 1.09 0.53 1.35 1.18 1.32 
α-Me-Val 0.40 1.00 0.00 0.55 1.02 0.16 2.53 1.12 0.90 1.65 1.00 0.00 
α-Me-Ser 0.68 1.25 1.30 0.94 1.11 0.59 1.59 1.00 0.00 2.61 1.08 0.54 
α-Me-Phe 3.18 1.08 0.64 4.16 1.18 0.59 3.18 1.06 0.68 4.16 1.00 0.00 
α-Me-Tyr 0.66 1.12 0.46 1.05 1.14 0.67 0.66 1.00 0.00 1.05 1.07 0.54 
α-Me-m Tyr 0.53 1.63 5.57 0.82 1.42 2.54 0.53 1.50 7.39 0.82 1.31 2.22 
α-Me-Trp 0.56 3.04 11.08 0.83 3.56 20.51 0.56 1.91 6.96 0.83 2.07 13.31 
α-Me-DOPA 0.66 2.11 3.09 1.98 1.52 2.52 1.45 1.85 5.10 1.98 1.29 1.68 
Average values   1.53 2.77   1.50 3.51   1.32 2.70   1.25 2.45 
 
Table 3.11.: α-methylated AAS measured on CSP 3 and 4 
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Aminosulfonic AAS 
When separating aminosulfonic acids it was observed that with CSP 4 better resolution values 
could be achieved, also when using 50 % aprotic ACN in the mobile phase. Nearly none 
aminosulfonic acid could be separated with 50/50 mobile phase condition on CSP 3.  
  CSP 3 CSP 4 CSP 3 CSP 4 
  100 % MeOH 100 % MeOH 50 % ACN 50 % ACN 
aminosulfonic acids k1 α RS k1 α RS k1 α RS k1 α RS 
Homocysteic acid 1.76 1.18 1.21 2.69 1.00 0.00 2.09 1.26 1.19 2.96 1.11 0.60 
Cysteic acid 2.20 1.00 0.00 2.19 1.11 0.60 2.59 1.00 0.00 2.28 1.13 0.49 
 trans-2-ACHSA 2.02 1.00 0.00 2.71 1.09 0.60 2.52 1.00 0.00 3.46 1.05 0.39 
 cis-2-ACHSA 1.11 1.22 0.56 1.37 1.26 1.18 1.60 1.00 0.00 1.87 1.18 0.68 
cis-3-ACHSA 1.02 1.00 0.00 2.36 1.16 0.87 2.42 1.00 0.00 4.86 1.04 0.29 
 trans-2-Me-2-
ACHSA 1.19 1.32 2.01 1.44 1.49 5.31 2.00 1.00 0.00 1.82 1.19 3.83 
2-tert-Bu-Tau 1.06 2.27 2.93 1.18 2.79 6.47 1.41 2.04 1.69 1.52 2.62 4.97 
2-Et-Tau 1.69 1.43 1.25 2.27 1.52 2.48 1.97 1.65 1.16 2.85 1.54 2.23 
2-Me-Tau 1.95 1.00 0.00 2.81 1.16 0.83 2.69 1.00 0.00 3.65 1.17 0.69 
Pro-Me-SO3H 1.31 1.12 0.82 1.86 1.34 1.35 1.50 1.00 0.00 2.03 1.22 0.73 
2-isopropyl-Tau 1.45 1.56 1.60 1.91 1.63 2.99 1.86 1.55 0.79 2.36 1.67 2.58 
2-phenyl-Tau 1.44 1.28 1.22 1.91 1.37 2.75 2.57 1.00 0.00 2.57 1.31 1.82 
Average values   1.31 1.68   1.34 1.69   1.31 2.09   1.35 1.94 
 
Table 3.12.: aminosulfonic acids measured on CSP 3 and 4 
Aromatic AAS  
Almost all aromatic analytes could be enantioseparated on both CSPs using them under each 
mobile phase condition. When using 50 % ACN in the mobile phase 72 % of the aromatic 
analytes were baseline separated in both CSPs and when using 100 % MeOH as mobile phase 
80 % of the aromatic analytes were baseline separated on CSP 3 and only 44 % on CSP 4. The 
majority of baseline separation (80 %) was found when using CSP 3 in 100 % MeOH. Tryptophan 
and tryptophan derivatives displayed greater selectivity values on CSP 4. 
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  CSP 3 CSP 4 CSP 3 CSP 4 
  100 % MeOH 100 % MeOH 50 % ACN 50 % ACN 
aromatic amino 
acids k1 α RS k1 α RS k1 α RS k1 α RS 
Phe 0.80 1.34 3.49 1.03 1.16 1.06 2.21 1.34 4.32 2.50 1.19 1.17 
p-F-Phe 0.84 1.33 1.89 1.10 1.11 1.10 2.38 1.39 2.38 2.60 1.18 2.13 
p-Cl-Phe 1.05 1.39 3.33 1.34 1.12 1.48 2.94 1.46 3.62 3.14 1.20 2.49 
p-Br-Phe 1.16 1.42 4.39 1.48 1.13 1.62 3.22 1.48 5.14 3.40 1.21 2.66 
o-F-Phe 0.78 1.35 3.57 1.00 1.16 1.14 2.18 1.37 5.12 2.29 1.21 1.63 
β-Phe 0.82 1.26 2.12 1.17 1.15 1.95 2.02 1.56 4.32 2.49 1.31 5.79 
β-homo-Phe 2.36 1.00 0.00 3.22 1.00 0.00 5.89 1.18 3.20 7.09 1.11 1.84 
α-Me-Phe 3.18 1.08 0.64 4.16 1.18 0.59 7.05 1.06 0.68 7.77 1.00 0.00 
p-Amino-Phe 0.49 1.31 3.35 0.66 1.14 0.77 1.44 1.31 4.47 1.68 1.23 1.14 
DOPA 1.36 1.00 0.00 1.71 1.00 0.00 3.68 1.00 0.00 4.30 1.07 0.37 
α-Me-DOPA 0.66 2.11 3.09 1.05 1.52 2.52 1.84 1.85 5.10 2.62 1.29 1.68 
                  
Tyr 0.86 1.28 2.12 1.20 1.13 0.86 2.42 1.30 2.32 2.89 1.24 1.61 
m Tyr 1.01 1.17 0.71 1.34 1.06 0.46 2.92 1.14 1.32 3.43 1.08 0.59 
α-Me-Tyr 0.53 1.12 0.46 0.82 1.14 0.67 1.61 1.00 0.00 2.17 1.07 0.54 
α-Me-m Tyr 0.56 1.63 5.57 0.83 1.42 2.54 1.55 1.50 7.39 1.98 1.31 2.22 
OMe-Tyr 0.92 1.39 3.89 1.21 1.15 1.36 2.38 1.40 4.99 2.74 1.19 1.72 
                  
Trp 1.45 1.26 2.92 1.98 1.61 7.62 3.27 1.05 0.59 3.93 1.26 3.21 
α-Me-Trp 0.83 3.04 11.08 1.35 3.56 20.51 1.94 1.91 6.96 2.94 2.07 13.31 
1-Me-Trp 1.69 1.14 1.75 1.94 1.36 4.98 3.42 1.06 0.55 3.68 1.12 1.64 
5-HTP 1.78 1.14 1.52 2.24 1.43 5.23 3.66 1.00 0.00 4.48 1.13 1.32 
                  
Baclofen 2.72 1.32 2.28 4.63 1.28 5.43 8.96 1.42 3.88 11.92 1.34 6.99 
Phenylglycine 0.87 1.22 1.57 1.31 1.04 0.54 2.70 1.11 1.39 3.20 1.00 0.00 
Kynurenine 1.39 1.26 3.34 1.98 1.10 1.31 3.13 1.28 4.13 3.79 1.12 1.61 
1-Naphtylalanine 1.20 1.53 5.31 1.60 1.12 1.68 3.01 1.56 4.65 3.44 1.14 1.74 
Tic 0.91 1.34 4.07 1.11 1.32 2.20 1.94 1.32 4.92 2.17 1.27 2.08 
Average values   1.38 2.90   1.30 2.70   1.32 3.26   1.21 2.38 
 
Table 3.13.: aromatic acids measured on CSP 3 and 4 
 
Proteinogenic AAS  
When using more aprotic content in the mobile phase the average values of selectivity and 
resolution were increasing on CSP 3 and the values were decreasing on CSP 4.  
The retention-factors were higher on CSP 4 for every analyte with both mobile phases. In many 
cases retention clearly increased in both mobile phases.  
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  CSP 3 CSP 4 CSP 3 CSP 4 
  100 % MeOH 100 % MeOH 50 % ACN 50 % ACN 
proteogenic amino 
acids k1 α RS k1 α RS k1 α RS k1 α RS 
Ala 0.70 1.22 1.55 0.89 1.13 0.48 2.28 1.18 1.79 2.38 1.11 0.60 
Val 0.60 1.35 2.13 0.74 1.22 1.51 2.06 1.27 2.39 2.12 1.22 1.94 
Leu 0.74 1.34 3.12 0.86 1.22 1.63 2.41 1.31 3.96 2.35 1.19 2.03 
Ser 1.05 1.00 0.00 1.26 1.09 0.56 3.42 1.00 0.00 3.80 1.00 0.00 
Thr 0.77 1.26 0.80 1.03 1.25 1.31 2.37 1.29 1.20 2.67 1.30 1.46 
Ile 0.65 1.33 1.92 0.80 1.24 2.02 2.27 1.24 2.34 2.25 1.24 2.58 
Phe 0.80 1.34 3.49 1.03 1.16 1.06 2.21 1.34 4.32 2.50 1.19 1.17 
Tyr 0.86 1.28 2.12 1.20 1.13 0.86 2.42 1.30 2.32 2.89 1.24 1.61 
Trp 1.45 1.26 2.92 1.98 1.61 7.62 3.27 1.05 0.59 3.93 1.26 3.21 
Met 0.99 1.24 1.55 1.24 1.10 0.96 3.02 1.27 1.88 3.01 1.11 1.04 
Lys 3.77 1.23 1.98 10.05 1.18 2.27 n.d 13.48 1.00 0.00 
Pro 0.94 1.80 6.72 1.07 1.56 4.30 1.43 2.34 10.15 1.44 1.94 5.96 
Asn 1.20 1.15 1.27 1.54 1.20 1.00 2.74 1.24 2.41 7.57 1.00 0.00 
Gln 0.86 1.26 0.69 1.24 1.00 0.00 2.22 1.25 0.78 2.61 1.26 1.38 
Asp 2.53 1.00 0.00 3.20 1.05 0.33 6.56 1.00 0.00 7.44 1.00 0.00 
Glu 1.38 1.00 0.00 1.79 1.10 0.59 4.20 1.00 0.00 4.67 1.15 0.66 
Arg 4.68 1.00 0.00 2.64 2.37 1.38 n.d n.d 
His 1.61 1.37 2.24 4.45 1.40 1.59 n.d 9.71 1.58 0.87 
Average values   1.24 1.60   1.27 1.33   1.28 2.24   1.22 1.32 
 
Table 3.14.: proteinogenic amino acids measured on CSP 3 and 4 
 
 
 
Figure 3.13.: retention-factors shown on CSP 3 and CSP 4 for certain analytes 
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Figure 3.14.: retention-factors shown on CSP 3 and CSP 4 for certain analytes 
 
 
The k1-values are higher on CSP 4. Maybe the isopropyl moiety in (S)-configuration assisted in 
the interactions between the amino acid analytes and the SO or quinidine is the reason. 
The resolution-values of the analytes differ enormously between the two CSPs, but the 
“separation power” is similar and thus, the analytes can be at least baseline separated on both 
CSPs. The configuration of the side chain and of the cinchona alkaloid seemed to play a big role 
in that case.  
 
 
Change of elution order 
According to Lindner and Lämmerhofer43 the elution order of N-protected amino acids changes 
when changing from the tert-butyl-QN-AX selector to the tert-butyl-QD-AX selector. Does this 
phenomenon cause with chiral amino acids at chiral zwitterionic selectors? 
In table 3.15 the elution orders of chosen analytes were listed. Listed L-D means that the L-
enantiomer elutes before the D-enantiomer. 
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  100 % MeOH 50 % ACN 
  CSP 3 CSP 4 CSP 3 CSP 4 
analytes EO EO EO EO 
α-Me-Phe L-D D-L /// /// 
α-Me-Tyr /// D-L /// L-D 
α-Me-DOPA L-D D-L L-D D-L 
Nipecotic acid S-R R-S S-R R-S 
Homocysteic acid D-L /// D-L /// 
Cysteic acid /// L-D /// /// 
2-tert-Bu-Tau S-R R-S S-R R-S 
2-Et-Tau S-R R-S S-R R-S 
2-Me-Tau /// R-S /// R-S 
Pro-Me-SO3H S-R R-S /// R-S 
2-isopropyl-Tau L-D D-L L-D D-L 
2-phenyl-Tau L-D D-L n. d.  D-L 
Phe D-L L-D D-L L-D 
p-F-Phe D-L L-D D-L L-D 
p-Cl-Phe D-L L-D D-L L-D 
DOPA /// /// /// L-D 
Tyr D-L L-D D-L L-D 
OMe-Tyr D-L L-D D-L L-D 
Trp L-D D-L L-D D-L 
1-Me-Trp L-D D-L D-L D-L 
5-HTP L-D D-L /// D-L 
Phenylglycine D-L L-D D-L /// 
Kynurenine D-L L-D D-L L-D 
1-Naphtylalanine D-L L-D D-L L-D 
Tic R-S S-R R-S S-R 
Ala n.d. L-D /// L-D 
Val D-L L-D D-L L-D 
Leu D-L L-D D-L L-D 
Ser /// L-D /// /// 
Thr /// L-D D-L L-D 
Ile /// L-D D-L L-D 
Met D-L L-D D-L L-D 
Lys /// L-D /// /// 
Pro D-L L-D D-L L-D 
Asn D-L L-D D-L /// 
Gln D-L /// D-L /// 
 
Table 3.15.: elution order when using CSP 3 and 4 (n.d.: not determined, /// no value) 
 
 72 
Asp /// D-L /// /// 
Glu /// D-L /// /// 
Glu /// D-L /// /// 
His /// L-D /// /// 
allo-Ile D-L L-D D-L L-D 
Neopentylglycine D-L L-D D-L L-D 
tert-Leu D-L L-D D-L L-D 
Pipecoloc acid D-L L-D D-L L-D 
N-Me-Leu L-D D-L L-D D-L 
trans-4-OH-Pro L-D L-D L-D L-D 
cis-4-OH-Pro /// D-L D-L /// 
Nor-Leu D-L L-D D-L L-D 
Nor-Val D-L L-D D-L L-D 
          
 
Continue table 3.15.: elution order when using CSP 3 and 4 (n.d.: not determined, /// no separation) 
 
By testing the whole analyte set it was confirmed that the “pseudo”-enantiomeric behavior of 
QN and QD was decisive resulting in switching elution orders of enantiomers. Therefore one 
can state that the quinine and quinidine moiety were crucial for recognition of the chiral 
analytes.  
 
Figure 3.14 and 3.15 depict enantioseparation of proline on CSP 3 and CSP 4. The elution order 
changed when using the pseudo-enantiomeric CSP but with changing the mobile phase elution 
order was preserved.  
 
 
 
 
Figure 3.15.: right: Proline on CSP 3, 100 % MeOH; left: Proline on CSP 4, 100 % MeOH 
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Figure 3.16.: right: Proline on CSP 3, 50/50 MeOH/ACN; left: Proline on CSP 4, 50/50 MeOH/ACN 
 
 
Figure 3.16 shows 5-HTP enantiomers that changed the elution order when changing the CSPs. 
In this case the use of higher aprotic solvent amount led to a much better resolution-value. 
 
 
 
Figure 3.17.: right: 5-HTP on CSP 3, 100 % MeOH; left: 5-HTP on CSP 4, 100 % MeOH 
 
In some cases the elution order did not change when switching from CSP 3 to CSP 4. These 
exceptions were trans-4-hydroxy-proline where no change in elution order could be observed 
and cis-4-hydroxy-proline (also see table 3.15). 
A reversal of elution order for certain analytes also occurred when the mobile phase was 
changed. With changing the mobile phase the elution order of α-methyl-tyrosine-enantiomers 
switched when using CSP 4 and of 1-methyl-tryptophan-enantiomers when using CSP 3. 
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To sum up, when changing from (R)-isopropyl-Tau-QD to (S)-isopropyl-Tau-QN a change of 
elution order for almost all analytes could be observed. When the mobile phase on the same 
CSP was changed the elution order did not change for all but one case. With changing not only 
the configuration in the SCX-part but also the configuration in the WAX-part (from QD to QN) of 
the selector, it was shown that the phenomenon of switching elution orders depends on the 
configuration in the WAX-part of the selector. QN and QD seem to be the driving force for chiral 
recognition and therefore elution orders.  
 
 
 
3.10. Comparison: side chain of CSP 2, 4, 5 and 6 
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By testing different ZWIX-CSPs the question was posed which chiral side chain gave the best 
selectivity. To answer this question four CSPs were chosen to be compared to each other. The 
side chains have steric groups of different size, structure and they are all in (S)-configuration. 
The k1-values of different analytes were compared to each other. 
CSP 2 has an aromatic ring, where additional π-π-interactions to the quinoline moiety of the 
ZWIX-SO can be found. CSP 5 has a similar, but more sterically demanding side chain than CSP 
4. 
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To see which CSPs interact strongly with the analytes the k1-values were compared. CSP 2 had 
the lowest retention and CSP 6 the highest retention. When comparing k1-values from aromatic 
analytes on CSP 4 and 5 greater k1-values were observed on CSP 4. The same results can be 
seen when comparing the k1-values of phenylalanine derivatives of CSP 4 and 6. 
Hoping that the aromatic ring of CSP 2 would interact with the aromatic analytes and support 
retention, this was not the case. The phenyl ring was maybe too sterically demanding to allow 
better interaction between the analyte and the selector. 
 
 
Figure 3.18.: retention-factors of certain analytes using 100 % MeOH 
 
Figure 3.18 depicts that on CSP 2 the retention-factor of each analyte was smaller than the 
retention factors of analytes measured on the other CSPs with a non-aromatic side chain. 
When measuring with MeOH/ACN (50/50) the β-AAS showed greater retention on CSP 4 
compared with the retention-values of CSP 5 and CSP 6. This also counted for the aromatic 
analytes. According to the k1-values the isopropyl-moiety of CSP 4 supported stronger retention 
to amino sulfonic acids than the isobutyl-moiety of CSP 5. Again the k1-values were similar 
when using CSP 4, 5 and 6 with higher amount of aprotic solvent in the mobile phase.  
In both mobile phase conditions the k1-values measured on ACHSA-Tau-QN (CSP 6) were the 
highest where as phenyl-Tau-QN (CSP 2) exhibited the lowest retention. 
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Figure 3.19.: retention-factors of certain analytes using 50 /50 MeOH/ACN 
 
Considering histogram 3.20 the majority of the analytes had selectivity-factors between 1.10 
and 1.49. 2-(S)-isoprop-Tau-QN (CSP 4) showed the biggest number of high selectivity-values. 
On phenyl-Tau-QN (CSP 2) compared with the other CSPs had the greatest number of non-
separated enantiomers. 
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Figure 3.20.: number of analytes which have different α-values 
 
When comparing one analyte on four different CSPs it was seen that there were some 
differences in the peak shape. Crucial for the peak shape is the asymmetry factor AS. 
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Figure 3.21.: peak tailing of (L)-nor-leucine using different CSPs 
 
The AS-values in the figure 3.21 show that peak tailing occurs in different dimension on every 
four CSPs. 2-(S)-isopropyl-Tau-QN (CSP 4) has the lowest AS-value and the smallest peak tailing. 
The strongest peak tailing occurs when using 2-(S)-isobutyl-Tau-QN (CSP 5), where it is not sure 
if the strong tailing comes from the kind of the SCX-part or from the bad packing of the column.  
 
Comparing all four CSPs 2-(S)-isopropyl-Tau-QN (CSP 4) gave the best values, followed by the 
ACHSA-Tau-QN (CSP 6).  
CSP 2 gave worse results like the other CSPs (most amino acids could not be enantioseparated) 
but the peak shape was even better than the peak shape on CSP 6. CSP 4 showed the best 
separation-values compared to the other and also the fewest amount of non-separated amino 
acids. Furthermore, the peak shapes on CSP 4 seems to be the best.  
The results revealed that the isopropyl-moiety (CSP 4) is most beneficial for overall 
enantioselectivity of the zwitterionic analytes. 
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4. Experimental Part 
4.1. Materials and Methods 
Mass spectrometry measurements were performed on a PE Sciex API quadrupol mass 
spectrometer with an electrospray ionization source with 1100 Series CL/MSD Trap ion-trap 
MS-system. The mass spectrometer was hyphenated with a HPLC (Agilent 1100 Serien) of 
Agilent technologies. The measurements were done in positive ionization mode.  
LC-MS measurements were carried out on a reversed phase column (RP-C18 Phenomenex 
Gemini, 150 x 3 mm ID, 3 µm) and a mobile Phase consisting of methanol (with 0.1 % formic 
acid) and water (with 0.1% formic acid). It was done in isocratic with 50/50, 55/45 and 60/40 
MeOH/water, respectively. 
 
Elemental–Analysis (CHNS) of the immobilized selector were performed on a CHNS-O Element 
analyzer (Carlo Erba, now Thermo Scientic, Germany) and the selector coverage of the silica 
was calculated from mass per cent of nitrogen. 
1H-NMR and 13C-NMR were recorded at room temperature with a Bruker DRX400 and DRX600 
spectrometer. The spectra were recorded in CD3OD, CDCl3 and D2O and the solvent signals were 
used as reference signals. The raw data were processed with SpinWorks software (Version 3). 
Thin layer chromatography (TLC) was performed on silica gel 60 F254 from Merck (Darmstadt, 
Germany). Column chromatography was performed on silica gel 60 (0.040-0.063 mm, Merck).  
MeOH (gradient grade quality, Merck), DCM (VWR), PE (Baker), EA (Fluka), toluene (VWR), DEE 
(Merck) and DCM (Fluka), distilled over CaH2, were used as solvents during the synthesis.  
For the synthesis of the chiral stationary phases the following substances were used: quinine 
and quinidine (both Buchler, Germany), CS2 (Fluka), KOH (Riedel-de Haen), H2O2 (30 %, Merck), 
HCOOH (98%, Fluka), CH3COOH  (98 %, Fluka), 4-Nitrophenyl chloroformate (>97%, Aldrich), 2-
amino-2-methyl-1-propanol (> 97 %, Fluka), (2S)-2-amino-2-phenylethaneol and (2R)-2-amino-
3-methylbutaneol (both Aaron chemistry Gmbh, Germany). 
The silica gel (3 µm, 120 Å, Daiso, Japan) was modified and endcapped in house. All CSPs were 
prepared by immobilization of the chiral selector onto 3-mercaptopropyl-modified and 
endcapped silica gel via radical addition with AIBN (Merck). The selector loading were 
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calculated on the nitrogen content (w-% N). Analysis of the filtrate by ESI-MS confirmed 
selector integrity during immobilization conditions. Each CSP was packed by Bischoff 
Chromatography (Leonberg, Germany) into stainless steel columns (each 250 x 3 mm I.D.). All 
chemical reactions were carried out under nitrogen atmosphere. 
 
 
 (2R)-2-amino-3-sulfopropanoic acid (D-Cysteic acid) 
Into a 50 ml flask 2.5 ml (77 mmol, 31 eq.) H2O2 (30 %), were added portionwise to 12.5 ml (331 
mmol, 133 eq.) of formic acid (98%). The solution was stirred in an ice bath (0°C) for one hour. 
Peroxyformic acid was formed.  After adding 0.313 g (2.5 mmol) of D-Cysteine the mixture was 
stirred over night at 0-5 °C and was covered with aluminium foil. The next day the solution was 
evaporated under reduced pressure (around 10-2 atm). Then ethanol was added for 
recrystallisation. The yield was 0.18 g (43 %) of white crystals. 
1H-NMR [CDCl3]: δ = 4.08 (s, 1H), 2.99 (s, 1 H), 2.94 (s, 1 H). 13C-NMR [CDCl3]: δ = 127.0 (CH), 
50.4 (CH2), 49.5 (CH2). 
 
 
4.2. Synthesis of CSP 1, CSP 2 and CSP 3 
2, Dimethylthiazolidine-2-thione 
In a 250 ml flask 1.72 g (19 mmol) of 2-amino-2-methyl-1-propanole was put and dissolved in  
100 ml aqueous solution KOH (1 M) under stirring. After adding 6.2 ml (100 mmol) CS2 it was 
refluxed using an oil bath at 100 °C (solution turned red).  It was stirred overnight at 100 °C (the 
solution turned green). After extracting with dichloromethane (3 x 50 ml) it was dried over  
Na2SO4.  A co-product (4,4-dimethyl-1,3-oxazolidine-2-thione) was also formed. The co-product 
was separated from the product by flash chromatography (PE : EA 3:1). The yield of 2 as white 
crystals was 0.98 g (35 %). 
1H-NMR [CDCl3]: δ = 8.02 (s, 1H), 3.34 (s, 2H), 1.51 (s, 6H). 
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Because of less amount of 2 all the reaction was repeated: 
For synthesizing 2 2.71 g of 2-amino-2-methyl-1-propanole (30 mmol), 9.1 ml of CS2 (150 mmol) 
and 150 ml KOH (1M) were used. The yield of 2 as white crystrals was 2.02 g (50 %). 
1H-NMR [CDCl3]: δ = not seen (br, s, 1H, NH3), 3.33 (s, 2H, CH2S), 1.50 (s, 6H, 2CH3). 13C-NMR 
[CDCl3]: δ = 199.2 (C=S), 68.0 (C4), 46.2 (CH2), 27.3 (CH3). 
 
 
3, 2-amino-2-methylpropane-1-sulfonic acid 
Into a 50 ml flask 5.8 ml H2O2 (30 %) was added portionwise to 28.9 ml of formic acid (98%). 
The solution was stirred in an ice bath (0°C) for one hour. Peroxy formic acid was formed.  After 
adding 0.85 g of dimethylthiazolidine-2-thione (5.8 mmol) the mixture was stirred over night at 
0-5°C and was covered with aluinium foil. The next day the solution was evaporated in a pear 
shape flask under reduced pressure (around 10-2 atm). Then ethanol was added.  After 
recrystallisation in methanol into the fridge was done overnight it was washed with acetonitrile. 
The yield was 0.40 g (45%) of white crystals. 
1H-NMR [CDCl3]:δ = 3.19 (s, 2H); 1.45 (s, 6H): 13C-NMR [CDCl3]: δ = 58.1 (CH2) , 52.8 (C4) , 25.7 
(CH3). 
Because of less amount of 3 all the reaction was repeated: 
For 3 were 2.02 g of 2 (13.7 mmol), 13.7 ml of H2O2 (30 %) and 68.5 ml of HCOOH (98%) used. 
The yield of 3 (white crystals) was 0.61 g (29%). 
1H-NMR [D2O]: δ = 3.22 (s, 2H, CH2S); 1.19 (s, 6H, 2CH3). 13C-NMR [D2O]: δ = 57.9 (CH2),  52.8 
(C4), 25.5 (CH3). 
 
 
5, 9-O-(4-nitrophenyloxycarbonyl)-quinine hydrochloride 
In a three-necked flask 8.02 g of quinine (4, 24.66 mmol) were dissolved in 550 ml of toluene 
followed by azeotropic distillation (removal of 1/3 of the solvent) using a Dean-Stark-apparatus. 
After cooling the mixture to room temperature (r. t.) under N2-atmosphere 5.06 g of  
4-nitrophenyl chloroformate (25 mmol) were added. The mixture was stirred at r. t. under  
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N2-atmosphere overnight. After filtration a pale yellow precipitation were yielded 
quantitatively.  The solid was washed with n-heptane (2 x 30 ml), dried under vacuum and 
stored under N2-atmosphere to avoid hydrolysis. 
 
 
6, dimethyl-taurine-quinine-selector 
After building the apparatus 80 ml of dichlormethane were distilled over a drying agent (CaH2). 
After adding 0.40 g of 2-amino-2methylpropane-1-sulfonic acid (2.6 mmol) into the three-
necked flask, the apparatus was put under a N2-stream and charged with the dry solvent under 
stirring. Under stirring 1.94 ml of BSA (7.8 mmol) was added via syringe. The mixture was 
refluxed (oil bath temperature 100 °C). Therefore the mixture not become clear overnight 1.43 
ml of BSA (5.8 mmol) was added. The mixture became clear and was cooled to r. t. under N2-
atmosphere.  
Then 1.37 g of 1 (2.6 mmol) was added portionswise and stirred overnight under N2-
atmosphere. The reaction was quenched with 2 ml MeOH (gradient grade quality) for one hour. 
Purification (4-Nitrophenol and quinine byproducts were separated) by flash column 
chromatography (DCM : MeOH 10 : 1 – 3 : 1) yielding 0.27 g (21 %) of 6 as white crystals. 
Because of less amount of 6 all the reaction was repeated: 
For the synthesis of 6 were used 0.61 g of 3 (4.0 mmol), 2.10 g of 5 (4.0 mmol, 1 eq.), 5.0 ml of 
BSA (20.0 mmol, 5 eq.) and 80 ml of dried DCM. The yield of 6 (white crystals) was 0.51 g (25 
%). 
1H-NMR [d4-MeOD]: δ =8.714 (d, 1H), 8.00 (d, 1H), 7.62 (d, 1H), 7.50 (dd, 1H), 7.45 (s, 1H) 
6.66 (s, 1H),  5.79 (m,1H), 5.11 (d, 1H), 5.03 (d, 1H), 4.04 (s, 3H), 3.81 (s, 1H), 3.65 (s, 1H), 3.40 
(d, 1 H), 2.94 (d, 1H), 2.71 (s, 1H) 2.22-2.14 (m, 2H), 1.88 (m, 1H), 1.72 (m, 1H), 1.54 (s, 2 H), 
1.48 (s, 3H), 1,42 (s, 3H). 13C-NMR [d4-MeOD]: δ = 160.8 (Car), 155.3 (C=O), 148.74 (CarH), 145.5 
(Car), 143.6 (Car), 138.9 (CH=), 132.3 (CarH), 128.0 (CH2=), 127.4 (Car), 124.3 (CarH), 120.5 (CarH), 
102.7 (CarH), 71.1 (CH), 60.6 (CH), 59.4 (CH2SO3H), 57.2 (OCH3), 45.6 (CH2), 38.3 (CH2), 38.3 (CH), 
28.9 (CH3), 28.4 (C4), 28.3 (CH3), 25.0 (CH2), 20.7 (CH2).  
(ESI, positive): 504.2 [M + H]+. 
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CSP 1, immobilization of the chiral selector 6 
After 2.4 g of (endcapped mercaptopropylsilane modified silica (3 µm) was weighed into the 
flask, 540 mg of the selector 6 was added to the mixture and to remove the oxygen a gentle N2-
stream was bubbled through for ten minutes. Then 60 mg of AIBN (0.4 mmol) were added. The 
reaction mixture was refluxed under a N2-stream for seven hours. After that, it was cooled to r. 
t. , the modified silica gel was collected by filtration, resuspended in 4.8 ml (2ml per gram silica) 
of MeOH (gradient grade quality), washed with MeOH (3 x 2 ml) and with DCM (2 x 2 ml). The 
filtrates were saved for selector recovery. At last the silica gel was transferred to a drying 
cabinet and dried under vacuum at 60 °C overnight. Elemental analysis: 1.071 % N results in SO 
loading of 255 µmol g-1. 
 
 
8, (4S)-4-phenyl-1,3-thiazolidine-2-thione 
In a 250 ml flask 4.11 g of (2S)-2-amino-2-phenylethanol (7, 30 mmol) was dissolved in 150 ml  
aqueous solution KOH (1 M) under stirring. After adding 9.1 ml of CS2 (100 mmol), it was 
refluxed at 100 °C (using an oil bath) overnight. The solution turned light yellow. Then it was 
extracted with DCM (3 x 70 ml), dried over Na2SO4. A co-product ((4S)-4-phenyl-1,3-oxazolidine-
2-thione) was also formed, but in less amount (controlled by TLC with PE : EA  3:1 and RP-HPLC  
with water : MeOH 50 : 50, 0.1 % FA; confirmed that there was very low amount of the co-
product). Thus, a separation by flash chromatography was not necessary. The product was 
evaporated and dried under vacuum. The yield of 8 as white crystals was 2.80 g (48 %). 
1H NMR [CDCl3]: δ = not seen (br, s, 1H), 7.42 (m, 5H), 5.34 (dd, 1H),  3.88 (dd, 1H), 3.50 (dd, 
1H). 13C-NMR [CDCl3]: δ = 129.8 (CarH) , 129.7(CarH), 126.6 (CarH), 51.3 (CH) , 42.0 (CH2). 
 
 
9, (2S)-2-amino-2-phenylethanesulfonic acid 
Into a 250 ml flask 12.7 ml of H2O2 (35 %)  (179 mmol, 71 eq.) was added portionwise to 63.6 ml 
of formic acid (98%) (766 mmol, 307 eq.). The solution was stirred in an ice bath (0°C) for one 
hour. Peroxyformic acid was formed. After adding 2.48 of 8 (12.7 mmol) the mixture was stirred 
overnight at 0-5°C with a cooling-aggregate. After that, the solution was evaporated DEE and 
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EtOH were added and the flask was put into the fridge for recrystallisation overnight. At last it 
was washed in diethyl ether and put in drying cabinet overnight. The Yield of 9 as white crystals 
was 0.89 g (35 %). 
1H-NMR [D2O]: δ = 7.43 (m, 5H, ArH), 4.70 (m, 1H, CH),  3.54 (dd, 1H in CH2), 3.47 (dd, 1H in 
CH2). 13C-NMR [D2O]: δ = 130.2 (CarH), 129.8 (CarH), 127.5 (CarH), 53.6 (CH2), 52.4 (CH).  
 
 
 10, 2-(S)-phenyl-taurine-quinine-selector 
80 ml of dichlormethane was distilled and collected over a drying agent (CaH2).  After adding 
0.82 g of 9 (4.1 mmol) into the three-necked flask, the apparatus was put under a N2-stream 
and charged with the dry solvent under stirring. Under stirring 5.04 ml of BSA (12.4 mmol, 5 
eq.) was added via syringe. The mixture was refluxed (oil bath temperature 100 °C) under N2-
atmosphere). After that, the mixture was cooled to r. t. 2.14 g of 5 (4.1 mmol, 1 eq.) was added 
portionswise and stirred overnight under N2-atmosphere. The reaction was quenched with 2 ml 
MeOH (gradient grade quality) for one hour. Purification (4-Nitrophenol and quinine 
byproducts were separated) by flash column chromatography (DCM : MeOH 9 : 1 – 6 : 1 – 3 : 1) 
yielded 1.12 g (50 %) of 10 as crème-brown crystals. 
1H-NMR [CD3OD]: δ =8.88 (d, 1H), 8.12 (d, 1H), 7.97 (d, 1H), 7.75 (dd, 1H), 7.68 (d, 1H),  7.32 (m, 
3H), 7.30 (m, 3H), 7.03 (s, 1H), 5.25 (m, 1H), 5.17 (d, 1H), 4.75 (m, 1H), 4.07 (s, 3H), 3.87 - 3.72 
(m, 2 H), 3.68 (s, 1H), 3.49 (m, 1H), 3.23 (d, 1H), 3.13 (d, 1H), 2.30 - 2.17 (m, 2H), 2.03 (m, 2H), 
1.82 (m, 1H). 13C-NMR [CD3OD]: δ = 160.3 (Car), 155.6 (C=O), 148.3 (CarH), 145.0 (Car), 143.5 (Car), 
139.5 (CH=), 131.2 (CarH), 131.0 (CarH), 130.2 (CarH), 128.8 (CarH), 125.6 (Car), 120.9 (CarH), 119.6 
(CarH), 118.1 (CH=), 102.2 (CarH), 71.4 (CH), 60.2 (CH), 58.1 (OCH3), 55.3 (CH2), 54.3 (CH), 46.4 
(CH2), 39.6 (CH2), 38.93 (CH), 35.0 (CH2), 28.8 (CH), 25.5 (CH2), 21.7 (CH2). MS (ESI, positive): 
552.4 [M+H]+. 
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CSP 2, immobilization of the chiral selector 10 
After 2.4 g of endcapped mercaptopropylsilane modified silica (3 µm) was weight into the flask, 
560 mg of the selector 10 was added to the mixture and to remove the oxygen a gentle N2-
stream was bubbled through for ten minutes. Then 60 mg of AIBN (0.4 mmol) were added. The 
reaction mixture refluxed (oil bath temperature 75-77 °C) under a N2-stream for seven hours. 
After that, it was cooled to r. t. , the modified silica gel was collected by filtration, resuspended 
in 4.8 ml (2ml per gram silica) of MeOH (gradient grade quality), washed with MeOH (3 x 2 ml) 
and with DCM (2 x 2 ml). The filtrates were saved for selector recovery. 
At last the silica gel was transferred to a drying cabinet and dried under vacuum at 60 °C over- 
night. Subjected to elmental analysis: 0.357 % N 85 µmol Selector pro gram silica (19 %) was 
immobilized. Because the immobilization was very bad, it was repeated with another approach: 
For repetition of the immobilization 2.3 g of the endcapped mercaptopropylsilane modified 
silica (3 µm, immobilized before with 85 µmol), 250 mg of the selector 10, 300 mg of AIBN and 
38 ml of MeOH (gradient grade quality). Subjected to the elemental analysis: 0.781 % N results 
in SO loading of 186 µmol g-1.  
 
 
12, 4-(R)-4-(propan-2-yl)-1,3-thiazolidine-2-thione  
In a 250 ml flask 3.09 g of (2R)-2-amino-3-methylbutan-1-ol (11, 30 mmol)) was put and 
dissolved in 150 ml aqueous solution KOH (1 M) under stirring. After adding 9.1 ml CS2 (150 
mmol, 5 eq.) it was refluxed at 100 °C (using an oil bath) overnight. The solution turned orange-
red.  It was stirred overnight (the solution turned dark red). After extracting with DCM (3 x 50 
ml) it was dried over Na2SO4.  A co-product ((4R)-4-(propan-2-yl)-1,3-oxazolidine-2-thione) was 
also formed. The co-product was separated from the product by flash chromatography (PE : EA 
3:1) yielding 3.53 g (73 %) of 12 (white crystals). 
1H-NMR  [CDCl3]: δ = 4.10 (dd, 1H), 3.58 (dd, 1H),3.38 (dd, 1H), 2.00 (dqq, 1H), 1.08 (d, 3H), 1.04 
(d, 3H). 13C-NMR [CDCl3]: δ = 67.7 (CH), 36.7 (CH2), 32.6 (CH), 19.3 (CH3), 18.8 (CH3). 
Because the immobilization was very bad, the whole preparation of the selector 16 and 
therefore 12 was repeated with another approach: 
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For 12 two approaches were made. For the first were used 3.43 g of 11 (33 mmol, 1 eq.), 9.1 ml  
of CS2 (150 mmol, 4.5 eq.) and 150 ml of KOH (1M).  
For the second experiment were used 2.51 g of 11 (24 mmol, 1 eq.), 7.4 ml of CS2 (122 mmol, 5 
eq.) and 150 ml KOH (1M). The solids of the first and of the second approaches were united. 
The co-product was separated from the product by flash chromatography (PE : EA  3 : 1). The 
product was evaporated and dried under vacuum.  
The whole yield of 12 as white crystals by flash chromatography was 3.04 g (75 %). 
1H-NMR [CDCl3]: δ = 8.04 (br s, 1H), 3.99 (dd, 1H), 3.42 (dd, 1H), 3.28 (dd, 1H), 1.91 (dqq, 1H), 
0.98 (d, 3H), 0.96 (d, 3H).13C-NMR [CDCl3]: δ = 201.5 (C=S), 70.4 (CH), 36.4 (CH), 32.45 (CH2), 
19.2 (CH3), 18.6 (CH3). 
 
13, (2R)-2-amino-3-methylbutane-1-sulfonic acid 
Into a 150 ml flask 15 ml of H2O2 (35 %) (447 mmol, 35 eq.) were added portionwise to 75 ml of  
formic acid (98%) (1.66 mol, 130 eq.) . The solution was stirred in an ice bath (0°C) for one hour. 
Peroxyformic acid was formed. After adding 2.41 g of 12 (15 mmol) to the mixture, it was 
stirred overnight at 0-5°C and covered with aluminium foil. The next day the solution was put in 
a pear shaped flask and evaporated under reduced pressure. A light yellow viscous substance 
was formed. Then diethyl ether and ethanol were added and the flask put into the fridge. No 
precipitation was formed, so it was evaporated under reduced pressure again, this time 
methanol was added and the flask put into the fridge for recrystallisation. At least it was 
washed in diethyl ether and put in drying cabinet overnight. The yield of 13 as white crystals 
was 0.79 g (32 %). 
1H-NMR [D2O]: δ= 3.51 (dd, 1H), 3.30 (dd, 1H), 3.09 (dd, 1H), 2.05 (m, 1H), 0.99 (d, 3H), 0.98 (d, 
3H). 13C-NMR [D2O]: δ = 54.2 (CH), 49.7 (CH2) , 30.6 (CH), 17.6 (CH3), 17.0 (CH3). 
Because the immobilization was very bad, the whole preparation of the selector 16 and 
therefore 13 was repeated with another approach: 
For 13 were used 3.06 g of 12 (19 mmol), 19ml of H2O2 (35 %) (586 mmol, 31 eq.) and 95 ml of 
H3CCOOH (98 %) (2.52 mol, 133 eq.). The yield of 13 as white crystals was 0.94 g (30 %).  
1H-NMR [D2O]: δ = 3.49 (d, 1H), 3.22 (dd, 1H), 3.10 (dd, 1H), 2.06 (m, 1H), 0.98 (d, 3H), 0.96 (d, 
3H). 13C-NMR [D2O]: δ = 54.2 (CH), 49.8 (CH2), 30.6 (CH), 17.7 (CH3), 17.0 (CH3). 
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15, 9-O-(4-nitrophenyloxycarbonyl)-quinidine hydrochloride 
In a three-necked flask 8.02 g of quinine (24.66 mmol) were dissolved in 300 ml of toluene 
followed by azeotropic distillation (removal of 1/3 of the solvent) using a Dean-Stark-apparatus. 
After cooling the mixture to room temperature (r. t.) under N2-atmosphere 5.04 g of  
4-nitrophenyl chloroformate (25 mmol, 1.01 eq.) were added. The mixture was stirred at r. t. 
under N2-atmosphere overnight. After filtration a pale yellow precipitation was separated. 
The solid was washed with n-heptane (2 x 30 ml), dried under vacuum and stored under 
N2-atmosphere to avoid hydrolysis. The yield of 15 as white solid was 12.42 g (96 %). 
 
 
16, (2R)-isopropyl-taurine-QD-selector 
After building the apparatus 80 ml of DCM was distilled and collected over a drying agent 
(CaH2).  After adding 0.67 g of 13 (4.0 mmol) into the three-necked flask, the apparatus was put 
under a N2-stream and charged with the dry solvent under stirring. With a syringe 4.94 ml of 
BSA (12 mmol, 5 eq.) was added under stirring. The mixture was refluxed (oil bath temperature   
100 °C) under N2-atmosphere. After the mixture was cooled to r. t. 
Then 2.10 g of 15 (4.0 mmol, 1 eq.) was added portionswise and stirred overnight under N2-
atmosphere. The reaction was quenched with 2 ml MeOH (gradient grade quality) for one hour. 
Purification (4-Nitrophenol and remaining active ester were separated) by flash column 
chromatography (DCM : MeOH 9 : 1 – 6 : 1 –  2 : 1) yielded 1.05 g (50 %) of 16 as crème-brown 
crystals. 
1H-NMR [CD3OD]: δ = 8.69 (d, 1H), 7.95 (d, 1H), 7.62 (d, 1H), 7.54 (d, 1H), 7.42 (d, 1H), 7.09 (s, 
1H), 6.26 (h, 1H), 5.27 (d, 1H), 3.99 (s, 3H), 3.95 (m, 1H), 3.71 (m, 1H), 3.61 (m, 1H), 3.21-3.14 
(m, 2H), 3.01(m, 2H), 2.95(m, 2H), 2.64(dd, 1H), 2.41 (m, 1H), 1.98 (s, 1H), 1.82 (m, 3H), 1.46 (m, 
1H), 0.88 (d, 2H), 0.85 (d, 2H).  13C-NMR [CD3OD]: δ =160.3 (Car), 156.9 (C=O), 147.9 (CarH), 145.0 
(Car), 144.3 (Car), 139.4 (CH=), 131.5 (CarH), 127.7 (Car), 124.2 (CarH), 119.6 (CarH), 117.6 (CH2=), 
102.3 (CarH), 72.0 (CH), 60.1 (CH), 57.1 (CH2SO3H), 55.6 (OCH3), 55.2 (CH), 54.5 (CH2), 50.8 
(2CH2), 50.4 (CH2), 39.2 (CH), 33.5 (CH), 29.2 (CH3), 24.6 (CH2), 21.2 (CH2), 19.7 (CH3), 18.3 
(CH3). (ESI, positive): 518.4 [M+H]+. 
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Because the immobilization was very bad, the preparation of the selector 16 was repeated with 
another approach: 
For 16 were used 1.02 g of 13 (61 mmol), 3.21 g of 15 (61 mmol, 1 eq.), 7.55 ml BSA (305 mmol, 
5 eq.) and 100 ml of absoluted DCM. The yield of 16 (crème-brown crystals) was 2.36 g (75 %). 
1H-NMR [CD3OD]: δ = 8.70 (d, 1H), 7.95 (d, 1H), 7.62 (d, 1H), 7.53 (s, 1H), 7.43 (d, 1H), 7.07 (s, 
1H), 6.25 (m, 1H), 5.26 (d, 1H), 4.00 (s, 3H), 3.94 (m, 1H), 3.70 (m, 1H), 3.59 (t, 1H), 3.20-3.13 
(m, 2H), 3.01 (m, 2H), 2.93 (m,1H), 2.63 (dd, 1H), 2.39 (m, 1H), 1.97 (s, 1H), 1.81 (m, 3H), 1.46 
(m, 1H), 0.88 (d, 2H), 0.85 (d, 2H). 13C-NMR [CD3OD]: δ =160.3 (Car), 157.0 (C=O), 147.9 (CarH), 
145.0 (Car), 144.4 (Car), 139.3 (CH=), 131.5 (CarH), 127.7 (Car), 124.2 (CarH), 119.6 (CarH), 117.5 
(CH2=), 102.3 (CarH), 72.1 (CH), 60.1 (CH), 57.1 (CH2SO3H), 55.6 (OCH3), 55.2 (CH), 54.5 (CH2), 
50.9 (2CH2), 50.3 (CH2), 39.3 (CH), 33.5 (CH), 29.2 (CH3), 24.7 (CH2), 21.2 (CH2), 19.7 (CH3), 18.3 
(CH3). (ESI, positive): 504.2 [M + H]+. 
 
CSP 3, Immobilization of chiral selector 16 
After 2.4 g of (endapped mercaptopropylsilane modified silica (3 µm) was weighed into the 
flask, 600 mg of the selector 16 were added (solved in 15 ml MeOH) to the mixture and to 
remove the oxygen a gentle N2-stream was bubbled through for ten minutes. Then 67 mg of 
AIBN (0.4 mmol) was added (solved in 5 ml MeOH). The reaction mixture refluxed (oil bath 
temperature at 75-77 °C) under a N2-stream for seven hours. After it was cooled to r. t. , the 
modified silica gel was collected by filtration, resuspended in 4.8 ml (2ml per gram silica) of 
MeOH (gradient grade quality), washed with MeOH (3 x 2 ml) and with DCM (2 x 2 ml). The 
filtrates were saved for selector recovery. At least the silica gel was transferred to a drying 
cabinet and dried under vacuum at 60 °C overnight. Subjected to elmental analysis: 0.333 % N 
in SO loading of 79 µmol g-1 (18 %) was immobilized.  
Because of the immobilization was very bad, the immobilization of the selector 16 was 
repeated with another approach: 
For CSP 3 were used 2.5 g of endcapped mercaptopropylsilane modified silica (3 µm), 582 mg of 
the selector 16, 600 mg of AIBN (37 mmol) and 30 ml of MeOH (HPLC grade quality). 
Elemental analysis: 1.152 % N results in SO loading of 274 µmol/g. 
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List of Abbreviations 
 
///  no value, no data 
AAS  free amino acids 
ACHSA  aminocyclohexanesulfonic acid 
AIBN  Azo-bis-isobutyronitril 
AX  anion exchanger 
BSA  O,N-Bistrimethylsilylacetamid 
CAD  charged aerosol detector 
CD  cylodextrine 
CDA  chiral derivatizing additives 
CMPA  chiral mobile phase agent 
CLEC  chiral ligand exchange chromatography 
CS2   carbon disulfide 
CSP  chiral stationary phase 
CX  cation exchanger 
DCM  dichloromethane 
DEA  diethylamine 
DEE  diethyl ether 
EA  ethyl acetate 
e. g.  exampla gratia, for example 
ESI  electrospray ionisation 
EtOH  ethanol 
FA  formic acid 
FDA   American Food and Drug administration 
GC  gas chromatography 
H2O2  hydrogen peroxide 
HCOOH formic acid 
H3CCOOH acetic acid 
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HPLC  high performance liquid chromatography 
IMCI  intramolecular counterion  
KOH  potassium hydroxide 
LC  liquid chromatography 
LC-MS  liquid chromatography-mass spectrometry 
MeOH  methanol 
MS  mass spectrometry 
n. d.  not determined 
NMR  nuclear magnetic resonance 
NP  normal phase mode 
PE   petrol ether 
PO  polar organic mode 
RP  reversed phase mode 
QN  quinine 
QD   quinidine 
SCX  strong cation exchanger 
r. t.  room temperature 
w-%  mass percent 
WAX  weak anion exchanger 
WAX-CSP weak anion exchanger - chiral stationary phase 
ZWIX  zwitterionic ion exchange 
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Abbreviations of analytes 
1-Me-Trp 1-methyl-tryptophan 
1-Naphtylalanine 1-naphtylalanine 
2-Et-Tau 2-amino-butyl-1-sulfonic acid 
2-Me-Tau 2-amino-propyl-1-sulfonic acid 
2-tert-Bu-Tau 2-amino-3,3-dimethylbutane-1-SA 
3,4-Hydroxyproline 3,4-hydroxyproline 
5-HTP 5-hydroxy-tryptophan 
5-oxo-Proline 5-oxo-proline 
  
Ala alanine 
allo-Ile allo-isoleucine 
allo-Thr allo-threonine 
α-Me-DOPA α-methyl-dihydroxyphenylalanine 
α-Me-Leu α-methyl-leucine 
α-Me-Phe α-methyl-phenylalanine 
α-Me-Ser α-methyl-serine 
α-Me-Trp α-methyl-tryptophan 
α-Me-m Tyr α-methyl-meta-tyrosine 
α-Me-Tyr α-methyl-tyrosine 
α-Me-Val α-methyl-valine 
Arg arginine 
Asn asparagine 
Asp aspartic acid 
  
Baclofen baclofen 
β-homo-Phe β-homo-phenylalanine 
β-Leu β-leucine 
β-Neopentylglycine β-neopentylglycine 
β-Phe β-phenylalanine 
  
cis-2-ACHSA cis-2-amino-cyclohexyanecarboxylic acid 
cis-3-ACHSA cis-3-amino-cyclohexyanecarboxylic acid 
cis-4-OH-Pro cis-4-hydroxy-proline 
Cysteic acid cysteic acid 
  
DOPA 3,4-dihydroxyphenylalanine 
  
erythro-beta erythro-β-methyl-cycloalanine 
  
Gln glutamine 
Glu glutamic acid 
  
His histidine 
Homocysteic acid homocysteic acid 
  
Ile iso-leucine 
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isopropyl-Tau 2-amino-3-methylbutane-1-sulfonic acid 
  
Kynurenine kynurenine 
  
Leu leucine 
Lys lysine 
  
m-Tyr meta-tyrosine 
Met methionine 
  
N-Me-Asp N-methyl-aparaginsäure 
N-Me-Glu N-methyl-glutamine acid 
N-Me-Leu N-methyl-leucine 
Neopentylglycine neopentylglycine 
Nipe nipecotic acid 
Nor-Leu nor-leucine 
Nor-Val nor-valine 
  
oF-Phe ortho-fluoro-phenylalanine 
OMe-Tyr O-methyl-tyrosine 
  
p-Amino-Phe para-amino-phenylalanine 
p-Br-Phe para-bromo-phenylalanine 
pCl-Phe para-chloro-phenylalanine 
p-F-Phe para-fluoro-phenylalanine 
Phe phenylalanine 
phenyl-Tau 2-amino-2-phenylethanesulfonic acid 
Phenylglycine phenylglycine 
Pipe pipecolic acid 
Pro proline 
Pro-Me-SO3H pyrrolidine-2-methanesulfonic acid 
  
Ser serine 
  
Tic 1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid 
tert-Leu tert-leucine 
Thr threonine 
threo-beta threo-β-methyl-cycloalanine 
trans-2-ACHSA  trans-2-amino-cyclohexyanecarboxylic acid 
trans-2-amino trans-2-aminocyclohexanecarboxylic acid 
trans-4-OH-Pro trans-4-hydroxy-proline 
 trans-2-Me-2-ACHSA trans-2-methyl-amino-cyclohexyanecarboxylic acid 
Trp tryptophan 
Tyr tyrosine 
  
Val valine 
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Conclusion 
The focus of the diploma thesis was the synthesis and chromatographic evaluation of novel 
zwitterionic CSPs. Different aminosulfonic acid functionalities were attached to cinchona 
alkaloid scaffold to synthesize chiral zwitterionic CSPs. By evaluation with HPLC it was 
characterized which CSP was promising for enantioseparation of zwitterionic analytes. A set of 
75 different amino acids, amino acid derivatives and aminosulfonic acids was applied for 
evaluation. 
 
In detail, dimethyl-Tau (CSP 1) was compared to Tau-QN (CSP 7) to prove if chiral information in 
the SCX-part is necessary for a successful enantioseparation.  
CSP 2 having a side chain with (S)-configuration at the SCX-part was compared with CSP 8 
exhibiting opposite configuration at the SCX-moiety to investigate how a different configuration 
in the SCX-part influences enantioseparation and elution order of enantiomers.  
The QD-based CSP 3 was compared to the “pseudo-enantiomeric“ QN-based CSP 4 to observe if 
a change in elution orders occurs.  
Moreover, four QN-based CSPs with different side chains in the SCX-part were compared to 
each other to determine which chiral side chain gives the best results in enantioseparation. 
Additionally, variations of the bulk mobile phase were carried out by changing the type and 
amount of the polar organic solvents. Its influence on chromatographic parameters as there are 
retention, enantioselectivity and resolution was discussed. 
Resolution-values and separation factors were increasing on average with higher ACN-amount 
in the mobile phase.  
 
In doing so, it was seen that enantioseparation was best with CSP 4 and CSP 6 where CSP 4 
affords good results for almost all amino acids. CSPs without any chiral information like CSP 1 
and CSP 7 were not suitable for enantioselective separations of the zwitterionic test 
compounds. 
With changing only the configuration in the SCX-part of the selector no effective change in 
elution order occurred.  
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When changing the cinchona alkaloid scaffold from quinine to quinidine and the configuration 
in the SCX-part from (S) to (R) a change in elution order for all but one analyte could be 
observed. Therefore, quinine and quinidine seem to be the driving force for chiral recognition in 
ZWIX-selectors.  
 
To summarize, synthesis of novel zwitterionic CSP were carried out successfully. By 
chromatographic evaluation new findings on enantioselective recognition were achieved. 
The synthesis path of these zwitterionic selectors and their application in enantioseparation of 
amino acids seems to be promising for future investigations. 
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Zusammenfassung 
In dieser Arbeit wurden die Synthese und die Evaluierung von neuen zwitterionischen chiralen 
stationären Phasen (CSPs) diskutiert. Diese zwitterionischen Selektoren (SO) bestehen aus 
einem Chinin- oder Chinidin-basierenden schwachen Anionenaustauscher (WAX), an dem durch 
chemische Modifikation ein starker Kationenaustauscher (SCX) in Form einer Sulfonsäure 
angebracht wurde. Durch Immobilisierung an ein modifiziertes Kieselgel wurde somit eine 
Zwitterionenaustauscherphase (ZWIX-CSP) hergestellt. 
Es wurden drei verschiedene ZWIX-CSPs synthetisiert und zusammen mit fünf weiteren ZWIX-
CSPs chromatographisch verglichen. Mittels HPLC-Evaluierung sollte bestimmt werden welcher 
Selektor die besten Ergebnisse bezüglich Enantiomerentrennung für zwitterionische Analyten 
liefert. Dafür wurde ein Set von 75 Aminosäuren und Aminosulfonsäuren verwendet. 
Es wurde festgestellt, dass eine chirale Seitenkette an der Kationenaustauscherseite nötig ist 
um Enantioselektivität für einen Großteil der Analyte zu erzielen. 
Im Weiteren wurde der Einfluss der Konfiguration im SCX-Teil als auch der Einfluss von QN und 
QD im WAX-Teil auf das Potential für Enantiomerentrennung und auf die Elutionsreihenfolge 
hin untersucht. Dabei wurde beobachtet, dass eine alleinige Änderung der Konfiguration im 
SCX-Teil für die Umkehr der Elutionreihenfolge nicht ausreichend ist, sondern bei ZWIX-CSPs 
dieses Phänomen noch immer durch QN und QD im Selektor gesteuert wird.  
Durch Evaluierung aller acht CSPs konnte herausgefunden werden, dass im Durschnitt die 
Auflösung und die Selektivität gute Werte aufweisen und sich bei einigen Analyten mit 
zunehmendem aprotischen Anteil in der mobilen Phase verbessern.  
Zusammenfassend kann festgehalten werden, dass diese zwitterionischen Phasen erfolgreich 
synthetisiert wurden. Durch die Evaluierung von diversen ZWIX-Phasen konnten viele 
Erkenntnisse in Bezug auf Enantiomerentrennung und Elutionsreihenfolge von verschieden 
Aminosäuren gewonnen werden. Diese Phasen zeigten bei einzelnen zwitterionischen 
Aminosäuren eine gute Trennung. Durch Modifikation der Aminosulfonsäure-Gruppe bei der 
Synthese lassen sich weitere neuartige ZWIX-Phasen herstellen. Das Forschungsgebiet ist noch 
nicht abgeschlossen und es befinden sich weitere neue ZWIX-CSPs in Entwicklung. 
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Appendix 
 
Table i: aromatic amino acids on dimethyl-Tau-QN (CSP 1), 100 % MeOH, 50mM FA & 25mM DEA 
 
Table ii: aromatic amino acids on dimethyl-Tau-QN (CSP 1), 75/25 MeOH/ACN, 50mM FA & 25mM DEA 
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Table iii: aromatic amino acids on dimethyl-Tau-QN (CSP 1), 50/50 MeOH/ACN, 50mM FA & 25mM DEA 
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Table iv: aliphatic amino acids on dimethyl-Tau-QN (CSP 1), 100 % MeOH, 50mM FA & 25mM DEA 
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Table v: aliphatic amino acids on dimethyl-Tau-QN (CSP 1), 50/50 MeOH/ACN, 50mM FA & 25mM DEA 
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Table vi: aromatic amino acids on 2-(S)-phenyl-Tau-QN (CSP 2), 100 % MeOH, 50mM FA & 25mM DEA 
 
Table vii: aromatic amino acids on 2-(S)-phenyl-Tau-QN (CSP 2), 50/50  MeOH/ACN, 50mM FA & 25mM 
DEA 
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Table viii: aliphatic amino acids on 2-(S)-phenyl-Tau-QN (CSP 2), 100 % MeOH, 50mM FA & 25mM DEA 
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Table ix: aliphatic  amino acids on 2-(S)-phenyl-Tau-QN (CSP 2), 50/50 MeOH/ACN, 50mM FA & 25mM 
DEA 
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Table x: aromatic  amino acids on 2-(R)-isopropyl-Tau-QD (CSP 3), 100 % MeOH, 50mM FA & 25mM DEA 
 
Table xi: aromatic amino acids on 2-(R)-isopropyl-Tau-QD (CSP 3), 50/50 MeOH/ACN, 50mM FA & 25mM 
DEA 
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Table xii: aliphatic amino acids on 2-(R)-isopropyl-Tau-QD (CSP 3), 100 % MeOH, 50mM FA & 25mM DEA 
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Table xiii: aliphatic amino acids on 2-(R)-isopropyl-Tau-QD (CSP 3), 50/50  MeOH/ACN, 50mM FA & 
25mM DEA 
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Table xiv: aromatic  amino acids on 2-(S)-isopropyl-Tau-QN (CSP 4), 100 % MeOH, 50mM FA & 25mM 
DEA 
 
Table xv: aromatic  amino acids on 2-(S)-isopropyl-Tau-QN (CSP 4), 50/50 MeOH/ACN, 50mM FA & 
25mM DEA 
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Table xvi: aliphatic  amino acids on 2-(S)-isopropyl-Tau-QN (CSP 4), 100 % MeOH, 50mM FA & 25mM 
DEA 
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Table xvii: aliphatic  amino acids on 2-(S)-isopropyl-Tau-QN (CSP 4), 75/25 MeOH/ACN, 50mM FA & 
25mM DEA 
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Table xviii: aliphatic  amino acids on 2-(S)-isopropyl-Tau-QN (CSP 4), 50/50 MeOH/ACN, 50mM FA & 
25mM DEA 
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Table xix: aromatic  amino acids on 2-(S)-isobutyl-Tau-QN (CSP 5), 100 % MeOH, 50mM FA & 25mM DEA 
 
Table xx: aromatic  amino acids on 2-(S)-isobutyl-Tau-QN (CSP 5), 75/25 MeOH/ACN, 50mM FA & 25mM 
DEA 
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Table xxi: aromatic  amino acids on 2-(S)-isobutyl-Tau-QN (CSP 5), 50/50 MeOH/ACN, 50mM FA & 25mM 
DEA 
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Table xxii: aliphatic amino acids on 2-(S)-isobutyl-Tau-QN (CSP 5), 100 % MeOH, 50mM FA & 25mM DEA 
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Table xxiii: aliphatic amino acids on 2-(S)-isobutyl-Tau-QN (CSP 5), 50/50 MeOH/ACN, 50mM FA & 
25mM DEA 
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Table xxiv: aromatic  amino acids on ACHSA-Tau-QN (CSP 6), 100 % MeOH, 50mM FA & 25mM DEA 
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Table xxv aromatic  amino acids on ACHSA-Tau-QN (CSP 6), 75/25 MeOH/ACN, 50mM FA & 25mM DEA 
 
 
Table xxvi: aromatic  amino acids on ACHSA-Tau-QN (CSP 6), 50/50 MeOH/ACN, 50mM FA & 25mM DEA 
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Table xxvii: aliphatic amino acids on ACHSA-Tau-QN (CSP 6), 100 % MeOH, 50mM FA & 25mM DEA 
 120 
                                                                                                                                                                                           
 
Table xxviii: aliphatic amino acids on ACHSA-Tau-QN (CSP 6), 75/25 MeOH/ACN, 50mM FA & 25mM DEA 
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Table xxix: aliphatic amino acids on ACHSA-Tau-QN (CSP 6), 50/50 MeOH/ACN, 50mM FA & 25mM DEA 
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Table xxx: aromatic  amino acids on Tau-QN (CSP 7), 100 % MeOH, 50mM FA & 25mM DEA 
 
Table xxxi: aromatic  amino acids on Tau-QN (CSP 7), 50/50 MeOH/ACN, 50mM FA & 25mM DEA 
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Table xxxii: aliphatic amino acids on Tau-QN (CSP 7), 100 % MeOH, 50mM FA & 25mM DEA 
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Table xxxiii: aliphatic amino acids on Tau-QN (CSP 7), 50/50 MeOH/ACN, 50mM FA & 25mM DEA 
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Table xxiv: aliphatic amino acids on 2-(R)-phenyl-Tau-QN (CSP 8), 100 % MeOH, 50mM FA & 25mM DEA 
 
 
Table xxxv: aromatic amino acids on 2-(R)-phenyl-Tau-QN (CSP 8), 100  % MeOH, 50mM FA & 25mM 
DEA 
 
Table xxxvi: aromatic amino acids on 2-(R)-phenyl-Tau-QN (CSP 8), 50/50 MeOH/ACN, 50mM FA & 
25mM DEA 
